Membrane-free ice nucleation proteins derived from fungi
Membrane-free fungal ice nucleating proteins with β-solenoid folds and disulfide-stabilized CRDs address the stability limitations of existing INPs, enabling efficient ice nucleation and broader applications.
Patent Information
- Application Number
- PCT/US2026/018463
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-05-09
- Filing Date
- 2026-03-10
- Publication Date
- 2026-11-19
AI Technical Summary
Existing ice nucleating proteins (INPs) are primarily membrane-bound and lack stability, limiting their application in diverse environments and uses.
Development of membrane-free ice nucleating proteins derived from fungi, featuring a central repeating domain (CRD) with a β-solenoid fold stabilized by intramolecular disulfide bonds, allowing for higher stability and efficient ice nucleation at higher temperatures.
The membrane-free fungal INPs facilitate ice nucleation at temperatures up to -2°C, enhancing applications in snowmaking, cryopreservation, and atmospheric processes.
Smart Images

Figure US2026018463_19112026_PF_FP_ABST
Abstract
Description
BSU:2000WDMEMBRANE-FREE ICE NUCLEATION PROTEINS DERIVED FROM FUNGI CROSS-REFERENCE TO RELATED APPLICATIONS
[0001] This application is a PCT International patent application of and claims priority to U.S. provisional patent application serial number 63 / 802,794 filed on May 9, 2025, the contents of which arc incorporated by¬ re ference in its entirety.TECHNICAL FIELD
[0002] The present disclosure relates in general to the field of ice nucleating proteins (INPs), and more particularly, to novel ice nucleating proteins (INPs) derived from fungi, which facilitate ice formation at high subzero temperatures.STATEMENT OF FEDERALLY FUNDED RESEARCH
[0003] This invention was made with government support under 2336558, 2116528, 2308172, and IOS1754721 awarded by the National Science Foundation and FA9550-24-1-0197 awarded by the Air Force Office of Scientific Research (AFOSR). The government has certain rights in the invention.INCORPORATION-BY-REFERENCE OF MATERIALS FILED ON COMPACT DISC
[0004] Tire present application includes a Sequence Listing which has been submitted in XML format via EFS-Web and is hereby incorporated by reference in its entirety. Said XML copy, created on , 2025, is named .xml and is , bytes in size.BACKGROUND
[0005] Without limiting the scope of the disclosure, its background is described in connection with bacterial ice nucleating proteins.
[0006] The crystallization of water is the most ubiquitous phase transition on Earth, influencing ecological interactions, atmospheric processes, and climate dynamics. Ice formation is thermodynamically favorable below 0 °C, but it is kinetically hindered due to the high energetic cost of forming an initial ice nucleus1. Above -46 °C, homogeneous ice nucleation is very slow, and various substrates can act as catalysts to heterogeneously accelerate ice nucleation. In nature, the freezing of water is facilitated by ice nucleators (INs) of biological and abiotic origins. Biological INs are found across all kingdoms of life2'7, with those from bacteria and fungi being the most efficient, enabling ice formation at temperatures as high as -2 °C8,9. In contrast, natural abiotic INs like mineral dust or organic aerosols, freeze water below -15 °C10, while silver iodide, a widely used artificial cloud-seeding agent, initiates ice formation around -6 °C11. Efficient biological INs can impact crop frost damage, cloud formation, and precipitation, and their unmatched efficiencies enabled applications in artificial snowmaking and cryopreservation1213. Despite the diversity of biological INs capable of nucleating ice above -10 °C, only bacterial INs have been fully sequenced and structurally characterized, serving as the key model for understanding biomolecular ice formation.
[0007] For example, the ice-nucleating activity of Gammaproteobacteria like Pseudomonas syringae originates from a highly conserved family of membrane-associated ice -nucleating proteins (INPs) encoded by the InaZ gene14. Hie InaZ protein consists of -1,200 residues and has a three-domain architecture, with an N-terminal membrane -anchoring domain, a central repeating domain (CRD), and a C-terminal capping domain. The CRD, which constitutes the majority of the structure, comprises 50-100 tandem repeats of a conserved 16-residue sequence and adopts a 0-solenoid fold. This rigid, repetitive architecture serves as a molecular scaffold for ice nucleation, with the conserved motifs Threonine-X-Threonine (TxT) and Serine-Leucine-Thrconinc (SLT) facilitating the ordering of intcrfacial water molecules to promote ice formation15. The CRD further enables the assembly of bacterial INPs into large functional aggregates, where ice-nucleating efficiency depends on the size and spatial organization of nucleation sites. This supramolecular organization relies on an intact membrane16 18, as individual INPs lack the templating area required to nucleate ice at high temperatures16 19.
[0008] However, despite the availability of bacterial ice nucleating proteins, a need remains for novel INPs that are more stable, not membrane-bound, and that are capable of use in a wide variety of uses and environments.SUMMARY
[0009] As embodied and broadly described herein, an aspect of the present disclosure relates to an icenucleating protein (INP) comprising: an amino acid sequence encoding a central repeating domain (CRD) comprising tandem repeat motifs that adopts a -solenoid fold and have at least 90, 91, 92, 93, 94, 95, 96. 97.98, 99, or 100% sequence identity to the CRD of SEQ ID NO: 1, 2, 3, or 12: and at least one of: an N-terminal flanking peptide immediately upstream of the CRD, wherein the N-terminal flanking peptide comprises at least one pair of cysteine residues spaced apart by no more than about 15 amino acids; or a C-terminal flanking peptide immediately downstream from the CRD, wherein the C-terminal flanking peptide comprises at least one pair of cysteine residues spaced apart by no more than about 15 amino acids; wherein the cysteine residues in the N-terminal flanking peptide, tire C-terminal flanking peptide, or both, are capable of forming intramolecular disulfide bonds that stabilize the 0-solenoid fold. In one aspect, each cysteine pair forms a disulfide bond. In another aspect, the CRD comprises a plurality of 16-amino acid repeat motifs with a consensus sequence TA(G / T)(S / T)Xn(SEQ ID NO:7). In another aspect, the N-terminal flanking peptide, the C-terminal flanking peptide, or both, are no more than about 20 amino acids from the CRD are conserved and have at least 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, or 100% sequence identity with one or more flanking cysteine-rich peptides of INPs from Mortierella atpina. Entomortierella parvispora, or Podila clonocystis of SEQ ID NO: 1, 2, 3, or 12, respectively. In another aspect, the INP is expressed in vitro or in a bacteria cell, a fungal cell, a yeast cell, a plant cell, a seed, a plant, an insect cell, a mammalian cell, or a cell infected with a virus. In another aspect, the INP does not comprise a hydrophobic or transmembrane region. In another aspect, the INP is secreted or free of a cellular membrane. In another aspect, the INP furthercomprises one or more protein purification tags selected from at least one of a His-tag, a FLAG-tag, a HA-tag, a Strep-tag, a Strep-II tag, a C9-tag, a glutathione S-transferase tag, HiBiT tag, a maltose-binding protein tag, a T7 tag, a V5 tag, an S tag, a SUMO tag, a TAP tag, a TRX tag, a calmodulin binding peptide, a chitin binding domain, a cellulose binding domain, a E2 epitope, a HaloTag, a HSV tag, a HBH tag, a KT3 tag or a myc-tag. In another aspect, the CRD is from Mortierella sp., Entomortierella sp., Podila sp., Gryganskiella sp., Pseudomonas sp., Xanthomonas sp., Pantoea sp., Erwinia sp., or Stenotrophomonas sp. In another aspect, the CRD is from a microorganism listed in Table 1.
[0010] A process for obtaining an ice -nucleating protein comprising: expressing in vitro or in a cell the icenucleating protein comprising an amino acid sequence encoding a central repeating domain (CRD) comprising tandem repeat motifs that adopts a 0-solenoid fold and have at least 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, or 100% sequence identity to the CRD of SEQ ID NO: 1, 2, 3, or 12; and at least one of: an N-terminal flanking peptide immediately upstream of the CRD, wherein the N-terminal flanking peptide comprises at least one pair of cysteine residues spaced apart by no more than about 15 amino acids; or a C-terminal flanking peptide immediately downstream from the CRD, wherein the C-terminal flanking peptide comprises at least one pair of cysteine residues spaced apart by no more than about 15 amino acids; wherein the cysteine residues in the N-terminal flanking peptide, the C-terminal flanking peptide, or both, are capable of forming intramolecular disulfide bonds that stabilize the 0-solenoid fold. In another aspect, an extract of the cell, a supernatant, or a whey thereof, does not comprise a lipid or hydrophobic portion of the extract. In another aspect, the growing at least one of Mortirella alpina (AfolNP). Entomortierella parvispora (A / / INP). or Podila clonocytis ( / iINP) is in a media at a first temperature and then growing in the media at a second temperature of about 0 to 10 degrees Celsius; extracting from the at least one of a Mortirella alpina (AfolNP), Entomortierella parvispora ( / 'j / INP). or Podila clonocytis (7’oINP) fungus; suspending and vortexing the extract in a solution; and isolating the ice-nucleating protein from the solution. In another aspect, isolating the icenucleating protein from the solution is by centrifugation, precipitation, settlement, or filtration. In another aspect, the solution is water and the first temperature is about room temperature. In another aspect, the icenucleating protein is isolated from at least one of spores or mycelial surfaces. In another aspect, the icenucleating protein further comprising one or more protein purification tags selected from at least one of a His-tag, a FLAG-tag, a HA-tag, a Strep-tag, a Strep-II tag, a C9-tag, a glutathione S-transferase tag, HiBiT tag. a maltose-binding protein tag, a T7 tag, a V5 tag, an S tag, a SUMO tag, a TAP tag, a TRX tag, a calmodulin binding peptide, a chitin binding domain, a cellulose binding domain, a E2 epitope, a HaloTag, a HSV tag, a HBH tag, a KT3 tag or a myc-tag . In another aspect, the ice-nucleating protein docs not comprise a hydrophobic or transmembrane region. In another aspect, the ice-nucleating protein is expressed in a cell other than M. alpina (AfolNP), E. parvispora ( / ri / INP). or P. clonocytis ( / % ! NP) In another aspect, the ice-nucleating protein is expressed in a fungi, yeast, bacteria, plant cell, seed, plant, insect, cyanobacteria, archaeal, protist,or mammalian cell. In another aspect, the CRD is from Mortierella sp., Entomortierella sp., Podila sp., Gryganskiella sp., or from related fungi in the class of the Mortierellomycetes. In another aspect, the CRD is from a microorganism listed in Table 1.
[0011] As embodied and broadly described herein, an aspect of the present disclosure relates to an aqueous extract comprising an ice-nucleating protein (INP) comprising: an amino acid sequence encoding a central repeating domain (CRD) comprising tandem repeat motifs that adopts a |3-solenoid fold and have at least 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, or 100% sequence identity to the CRD of SEQ ID NO: 1, 2, 3, or 12; and at least one of: an N-terminal flanking peptide immediately upstream of the CRD, wherein the N-terminal flanking peptide comprises at least one pair of cysteine residues spaced apart by no more than about 15 amino acids; or a C-terminal flanking peptide immediately downstream from the CRD, wherein the C-terminal flanking peptide comprises at least one pair of cysteine residues spaced apart by no more than about 15 amino acids; wherein the cysteine residues in the N-terminal flanking peptide, the C-terminal flanking peptide, or both, are capable of forming intramolecular disulfide bonds that stabilize the 0-solenoid fold. In one aspect, the INP from at least one o M. alpina (AfolNP), Entomortierella (A / zINP). P. clonocytis (PoINP), or from related fungi in the class of the Mortierellomycetes having at least 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, or 100% sequence identity to a central repeating domain (CRD) of SEQ ID NOS: 1, 2, 3, or 12, respectively, wherein at least one of the Mortirella alpina (AfolNP), Entomortierella parvispora ( / .7 / INP). Podila clonocytis (T’oINP), or from related fungi in the class of tire Mortierellomycetes is grown in a media at a first temperature and then growing in the media at a second temperature of about 0 to 10 degrees Celsius prior to extraction. In another aspect, the aqueous extract comprises protein having an apparent molecular weight of 100 kDa, 81.8 kDa, and 64 kD, respectively. In another aspect, the aqueous extract does not comprise a lipid or hydrophobic portion. In another aspect, the INP further comprises one or more protein purification tags selected from at least one of a His-tag, a FLAG-tag, a HA-tag, a Strep-tag, a Strep-II tag, a C9-tag, a glutathione S-transferase tag, HiBiT tag, a maltose -binding protein tag, a T7 tag, a V5 tag, an S tag, a SUMO tag, a TAP tag, a TRX tag, a calmodulin binding peptide, a chitin binding domain, a cellulose binding domain, a E2 epitope, a HaloTag, a HSV tag, a HBH tag, a KT3 tag or a myc-tag. In another aspect, the ice-nucleating protein does not comprise a hydrophobic or transmembrane region.
[0012] As embodied and broadly described herein, an aspect of the present disclosure relates to a polynucleotide that expresses an ice-nucleating protein (INP) comprising: a nucleic acid sequence encoding a central repeating domain (CRD) comprising tandem repeat motifs that adopts a p-solenoid fold and have at least 90. 91, 92, 93, 94, 95, 96, 97, 98, 99, or 100% sequence identity to the CRD of SEQ ID NO: 4. 5, or 6: and at least one of: an N-terminal flanking peptide immediately upstream of the CRD, wherein the N-terminal flanking peptide comprises at least one pair of cysteine residues spaced apart by no more than about 15 amino acids; or a C-terminal flanking peptide immediately downstream from tire CRD, wherein the C-terminalflanking peptide comprises at least one pair of cysteine residues spaced apart by no more than about 15 amino acids; wherein the cysteine residues in the N-tenninal flanking peptide, the C-terminal flanking peptide, or both, are capable of forming intramolecular disulfide bonds that stabilize the 0-solenoid fold. In one aspect, the polynucleotide further comprises a vector. In another aspect, the vector is in a host cell. In another aspect, the codon-usage of the polynucleotide is optimized for expression in a bacteria, fungi, insect, plant, or mammalian cell.
[0013] As embodied and broadly described herein, an aspect of the present disclosure relates to a method for increasing ice nucleation per microorganism, extract, supernatant, whey, or protein, comprising the steps of: blowing at least one stream of snow-like particles or snowflakes into ambient air, tire ambient air having a temperature just above, or below, a freezing point of water; forming an aqueous mixture comprising an icenucleating microorganism, extract, supernatant, whey, or protein comprising an amino acid sequence encoding a central repeating domain (CRD) comprising tandem repeat motifs that adopts a -solenoid fold and have at least 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, or 100% sequence identity to the CRD of SEQ ID NO: 1, 2, 3, or 12; and at least one of: an N-terminal flanking peptide immediately upstream of the CRD, wherein the N-terminal flanking peptide comprises at least one pair of cysteine residues spaced apart by no more than about 15 amino acids; or a C-terminal flanking peptide immediately downstream from the CRD, wherein the C-terminal flanking peptide comprises at least one pair of cysteine residues spaced apart by no more than about 15 amino acids: wherein the cysteine residues in the N-terminal flanking peptide, the C-terminal flanking peptide, or both, are capable of forming intramolecular disulfide bonds that stabilize the P-solenoid fold; and directing a spray or mist of water droplets into the stream to form snow or ice. In another aspect, the snow-like particles or snowflakes act as nucleating agents for water droplets to assist in formation of the snowflakes. In another aspect, the method further comprises adding at least a portion of tire snowflakes to the snow-like particles, wherein the snowflakes also provide a nucleating activity to water droplets. In another aspect, the snowflakes are added to the snow-like particles until a desired quantity of snow has been produced. In another aspect, the snow-like particles are formed from block- or chipped-ice in a snow-making machine. In another aspect, the method further comprises adding a polyol to the aqueous mixture selected from at least one of: sorbitol, maltitol, xylitol, erythritol, mannitol, isomalt, lactitol, or glycerol.
[0014] As embodied and broadly described herein, an aspect of the present disclosure relates to an apparatus for making snow, comprising: a snow-making machine having at least one chamber; a first inlet to the chamber operably connected to a source of ice or recycled snowflakes; a rotatable impeller within the chamber operable to form snow-like particles from ice; an outlet from the chamber operable to direct the snow-like particles formed within the chamber to be blown in a directed stream into ambient air having a temperature just above, or below, a freezing point of water; and at least one water sprayer, connected to a water source and an ice nucleating protein comprising an amino acid sequence encoding a central repeating domain (CRD) comprising tandem repeat motifs that adopts a P-solenoid fold and have at least 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, orBSU:2000WD100% sequence identity to the CRD of SEQ ID NO: 1, 2, 3, or 12; and at least one of: an N-terminal flanking peptide immediately upstream of the CRD, wherein the N-terminal flanking peptide comprises at least one pair of cysteine residues spaced apart by no more than about 15 amino acids; or a C-terminal flanking peptide immediately downstream from the CRD, wherein the C-terminal flanking peptide comprises at least one pair of cysteine residues spaced apart by no more than about 15 amino acids; wherein the cysteine residues in the N-terminal flanking peptide, the C-terminal flanking peptide, or both, are capable of forming intramolecular disulfide bonds that stabilize the fi-solcnoid fold. In another aspect, the snow-like particles or snowflakes act as nucleating agents for water droplets to assist in formation of the snowflakes. In another aspect, the apparatus further comprising adding at least a portion of the snowflakes to the snow-like particles, wherein the snowflakes also provide a nucleating activity to water droplets. In another aspect, the snowflakes are added to the snow-like particles until a desired quantity of snow has been produced. In another aspect, the snow-like particles are formed from block- or chipped-ice in a snow -making machine.
[0015] As embodied and broadly described herein, an aspect of the present disclosure relates to a method of preserving a biological sample, the method comprising: perfusing or contacting a biological sample with a composition comprising a non-toxic microorganism, extract, or protein thereof that expresses an ice nucleating protein comprising an amino acid sequence encoding a central repeating domain (CRD) comprising tandem repeat motifs that adopts a [3-solenoid fold and have at least 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, or 100% sequence identity to the CRD of SEQ ID NO: 1, 2. 3, or 12; and at least one of: an N-terminal flanking peptide immediately upstream of the CRD, wherein the N-terminal flanking peptide comprises at least one pair of cysteine residues spaced apart by no more than about 15 amino acids; or a C-terminal flanking peptide immediately do wn stream from the CRD, wherein the C-terminal flanking peptide comprises at least one pair of cysteine residues spaced apart by no more than about 15 amino acids; wherein the cysteine residues in the N-terminal flanking peptide, tire C-terminal flanking peptide, or both, are capable of forming intramolecular disulfide bonds that stabilize the P-solenoid fold; freezing the biological sample with the composition; and cry opreserving the biological sample at a high subzero temperature. In one aspect, the method further comprises thawing the biological sample. In another aspect, the biological sample comprises a cell, a tissue sample, an exosome, or a microvesicle. In another aspect, the composition further comprises a cry oprotectant selected from any one or more of dimethylsulfoxide, ethylene glycol, propylene glycol, polyvinyl alcohol, propane- 1,2-diol, 1,2-propanediol, 3-O-methyl-glucose. glycerol, sucrose, trehalose, stachyose, raffinose, an anti-freeze protein, or a polymer. In another aspect, a concentration of the ice nucleating protein in the hydrogel particle is greater than 0.5 mg / ml. In another aspect, a hydrogel particle can increase an ice nucleation temperature of a sample to higher than -5° C. In another aspect, the biological sample is an organ. In another aspect, the organ is a liver, a heart, or a kidney. In another aspect, the method minimizes ischemia-reperfusion damage of the organ.
[0016] As embodied and broadly described herein, an aspect of tire present disclosure relates to a process for freezing a water-based material that comprises mixing the water-based material with a non-toxic microorganism, extract, supernatant, whey, or protein an amino acid sequence encoding a central repeating domain (CRD) comprising tandem repeat motifs that adopts a 0-solenoid fold and have at least 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, or 100% sequence identity to the CRD of SEQ ID NO: 1, 2, 3, or 12; and at least one of: an N-terminal flanking peptide immediately upstream of the CRD, wherein the N-terminal flanking peptide comprises at least one pair of cysteine residues spaced apart by no more than about 15 amino acids; or a C-terminal flanking peptide immediately downstream from the CRD, wherein the C-terminal flanking peptide comprises at least one pair of cysteine residues spaced apart by no more than about 15 amino acids; wherein the cysteine residues in the N-terminal flanking peptide, the C-terminal flanking peptide, or both, are capable of forming intramolecular disulfide bonds that stabilize the [3-solenoid fold, wherein the microorganism, ice nucleating extract or ice nucleating protein induces ice nucleation and freezing of the water-based material at a temperature below -5° C. to produce a frozen product. In one aspect, a water-based material is a foodstuff, a paint, an acid, or a material with at least 10% water. In another aspect, the process further comprises storing a frozen foodstuff in cold storage. In another aspect, a foodstuff is liquid or semi-solid at room temperature. In another aspect, a foodstuff is ice cream or tofu confectionery, a fruit juice concentrate, a popsicle, a sauce, a soup, a sorbet, a gelato, a frozen yogurt, or a sherbet.
[0017] As embodied and broadly described herein, an aspect of the present disclosure relates to a water capture material, comprising: a microorganism, supernatant, whey, extract, or isolated ice nucleating protein (INP) comprises an amino acid sequence encoding a central repeating domain (CRD) comprising tandem repeat motifs that adopts a [3-solenoid fold and have at least 90, 91, 92, 93. 94, 95, 96, 97, 98, 99, or 100% sequence identity to the CRD of SEQ ID NO: 1, 2, 3, or 12; and at least one of: an N-terminal flanking peptide immediately upstream of the CRD, wherein the N-terminal flanking peptide comprises at least one pair of cysteine residues spaced apart by no more than about 15 amino acids; or a C-terminal flanking peptide immediately downstream from the CRD, wherein the C-terminal flanking peptide comprises at least one pair of cysteine residues spaced apart by no more than about 15 amino acids; wherein the cysteine residues in the N-terminal flanking peptide, tire C-terminal flanking peptide, or both, are capable of forming intramolecular disulfide bonds that stabilize the [3-solenoid fold, wherein the microorganism, whey, supernatant or ice nucleating protein extract or ice nucleating protein induces ice nucleation at atemperature below -5° C; wherein the water capture material is configured to condense water vapor into liquid water and desorb water vapor from the water capture material. In one aspect, the water capture material is further defined as at least one water harvesting device that encloses the water capture material. In another aspect, the water capture material is configured to adsorb water from surrounding air in adsorption mode. In another aspect, the water capture material further comprises: a heating element, and a condensing unit, wherein in production mode, the heating element is configured to heat the water capture material to induce desorption of water vapor from the watercapture material; and a condensing unit is configured to condense the water vapor into the water capture material. In another aspect, the water capture material further comprises: a cooling element that condenses water vapor released from the water capture material to liquid water. In another aspect, the water capture material is attached to a substrate. In another aspect, the water capture material further comprises: a control system configured to monitor and control adsorption, desorption, and condensation of water from the water capture material.
[0018] As embodied and broadly described herein, an aspect of the present disclosure relates to a method of harvesting water from surrounding air using an atmospheric harvester comprising: providing one or more water capture units configured to condense water vapor into liquid water or ice and desorb water vapor from the water capture material comprising a water capture material comprising a microorganism, whey, extract, or ice nucleating protein an amino acid sequence encoding a central repeating domain (CRD) comprising tandem repeat motifs that adopts a P-solenoid fold and have at least 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, or 100% sequence identity to the CRD of SEQ ID NO: 1, 2, 3, or 12: and at least one of: an N-terminal flanking peptide immediately upstream of the CRD, wherein the N-terminal flanking peptide comprises at least one pair of cysteine residues spaced apart by no more than about 15 amino acids; or a C-terminal flanking peptide immediately downstream from the CRD, wherein the C-tenninal flanking peptide comprises at least one pair of cysteine residues spaced apart by no more than about 15 amino acids; wherein the cysteine residues in the N-terminal flanking peptide, the C-terminal flanking peptide, or both, are capable of forming intramolecular disulfide bonds that stabilize the P-solenoid fold, wherein the microorganism, whey, extract or ice nucleating protein induces ice nucleation at a temperature below -5° C; adsorbing moisture from air in the one or more water capture units comprising the water capture material; desorbing water vapor from the water capture material in the at least one unit containing water capture material; and condensing the water vapor to produce liquid water. In one aspect, the method is further defined as at least one water harvesting device that encloses the water capture material. In another aspect, the water capture material is configured to adsorb water from surrounding air in adsorption mode. In another aspect, the method further comprises providing: a heating element, and a condensing unit, wherein in production mode, the heating element is configured to heat the water capture material to induce desorption of water vapor from the water capture material; and a condensing unit is configured to condense the water vapor into the water capture material. In another aspect, the method further comprises providing: a cooling element that condenses water vapor released from the water capture material to liquid water. In another aspect, the water capture material is attached to a substrate. In another aspect, the method further comprises providing: a control system configured to monitor and control adsorption, desorption, and condensation of water from the water capture material.
[0019] As embodied and broadly described herein, an aspect of the present disclosure relates to a composition for production of ice nucleation, snow, rain, cloud seeding, weather modification, cloud condensation, artificial cloud creation, ice nucleation in the atmosphere, hail suppression, or fog dispersal comprising: a dispersion ofan ice-nucleating protein (INP), the INP comprising: an amino acid sequence encoding a central repeating domain (CRD) comprising tandem repeat motifs that adopts a [3-solenoid fold and have at least 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, or 100% sequence identity to the CRD of SEQ ID NO: 1, 2, 3, or 12; and at least one of: an N-tenninal flanking peptide immediately upstream of the CRD. wherein the N-terminal flanking peptide comprises at least one pair of cysteine residues spaced apart by no more than about 15 amino acids; or a C-terminal flanking peptide immediately downstream from the CRD, wherein the C-terminal flanking peptide comprises at least one pair of cysteine residues spaced apart by no more than about 15 amino acids; wherein the cysteine residues in the N-tcrminal flanking peptide, the C-tcrminal flanking peptide, or both, arc capable of forming intramolecular disulfide bonds that stabilize the [3-solenoid fold, wherein the INP is in an amount sufficient to produce ice nucleation, snow, rain, cloud seeding, weather modification, cloud condensation, artificial cloud creation, ice nucleation in the atmosphere, hail suppression, or fog dispersal. In one aspect, the dispersion further comprises a substrate, carrier, diluent, buffer, protease inhibitors, solvent, salt, or combinations thereof. In another aspect, the dispersion further comprises a carrier or substrate selected from lignin, quartz, feldspar, cellulose, combinations and nanoparticles thereof for aerosolization. In another aspect, the composition further comprises one or more agents or indicia for tracing the rain, snow, or precipitation from seeding with the INP. In another aspect, the INPs are loaded into a cloud seeding flare or a dispersal apparatus. In another aspect, the INPs are expressed in vitro or in a bacteria cell, a fungal cell, a yeast cell, a plant cell, a seed, a plant, an insect cell, a mammalian cell, or a cell infected with a virus, or a supernatant thereof.
[0020] As embodied and broadly described herein, an aspect of tire present disclosure relates to a method for ice nucleation, production of snow, rain, cloud seeding, weather modification, as cloud condensation nuclei, artificial cloud creation, atmospheric ice nucleation, hail suppression, or fog dispersal, comprising: applying to a target region a dispersion of an ice-nucleating protein (INP), the INP comprising: an amino acid sequence encoding a central repeating domain (CRD) comprising tandem repeat motifs that adopts a [3-solenoid fold and have at least 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, or 100% sequence identity to the CRD of SEQ ID NO: 1, 2, 3, or 12; and at least one of: an N-terminal flanking peptide immediately upstream of the CRD, wherein the N-terminal flanking peptide comprises at least one pair of cysteine residues spaced apart by no more than about 15 amino acids; or a C-terminal flanking peptide immediately downstream from the CRD, wherein the C-terminal flanking peptide comprises at least one pair of cysteine residues spaced apart by no more than about 15 amino acids: wherein the cysteine residues in the N-terminal flanking peptide, the C-terminal flanking peptide, or both, are capable of forming intramolecular disulfide bonds that stabilize the |3-solenoid fold, wherein the INP is provided in an amount sufficient to produce ice nucleation, snow, rain, cloud seeding, weather modification, as cloud condensation nuclei, artificial cloud creation, atmospheric ice nucleation, hail suppression, or fog dispersal. In one aspect, the dispersion further comprises a substrate, carrier, diluent, buffer, protease inhibitors, solvent, salt, or combinations thereof. In another aspect, the dispersion further comprises acarrier or substrate selected from lignin, quartz, feldspar, cellulose, combinations and nanoparticles thereof for aerosolization. In another aspect, the method further comprises adding one or more agents or indicia for tracing the rain, snow, or precipitation from seeding w ith the INP. In another aspect, the INPs are loaded into a cloud seeding flare or a dispersal apparatus. In another aspect, the INPs are expressed in vitro or in a bacteria cell, a fungal cell, a yeast cell, a plant cell, a seed, a plant, an insect cell, a mammalian cell, or a cell infected with a virus, or a supernatant thereof.
[0021] As embodied and broadly described herein, an aspect of tire present disclosure relates to a method for detecting the effectiveness of production of ice nucleation, snow, rain, cloud seeding, weather modification, as cloud condensation nuclei, artificial cloud creation, atmospheric ice nucleation, hail suppression, or fog dispersal, comprising: dispersing an ice-nucleating protein (INP) into a target for ice nucleation, production of snow, rain, cloud seeding, weather modification, as cloud condensation nuclei, artificial cloud creation, atmospheric ice nucleation, hail suppression, or fog dispersal, the INP comprising: an amino acid sequence encoding a central repeating domain (CRD) comprising tandem repeat motifs that adopts a [3-solenoid fold and have at least 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, or 100% sequence identity to the CRD of SEQ ID NO: I, 2, 3, or 12; and at least one of: an N-terminal flanking peptide immediately upstream of the CRD, wherein the N-tenninal flanking peptide comprises at least one pair of cysteine residues spaced apart by no more than about 15 amino acids: or a C-terminal flanking peptide immediately downstream from the CRD, wherein the C-terminal flanking peptide comprises at least one pair of cysteine residues spaced apart by no more than about 15 amino acids; wherein the cysteine residues in the N-terminal flanking peptide, the C-terminal flanking peptide, or both, are capable of forming intramolecular disulfide bonds that stabilize the |3-solenoid fold; capturing one or more water or dust samples from a location downstream from the region seeded; and measuring in tire one or more water or dust samples an amount of INP in the one or more water or dust samples to determine if the INP produced desired ice nucleation, production of snow, rain, cloud seeding, weather modification, as cloud condensation nuclei, artificial cloud creation, atmospheric ice nucleation, hail suppression, or fog dispersal. In one aspect, the INP is measured by mass spectrometry, multiplex methods, Western blot, enzyme-linked immunosorbent assay (ELISA), sandwich ELISA, fluorescent-linked immunosorbent assay (FLISA), enzyme immunoassay (EIA), radioimmunoassay (RIA), electrochemiluminescence immunoassay, chemiluminescence immunoassay, an immuno assay based on detection of luminescence, fluorescence, chemiluminescence or electrochemiluminescence, immunoprecipitation assay, slot / blot assay, lateral flow assay, single molecule array, agglutination, high performance liquid chromatography (HPLC), thin layer chromatography (TLC), or combinations thereof. In another aspect, anti-INP antibody is used for Western blot, enzyme-linked immunosorbent assay (ELISA), sandwich ELISA, fluorescent-linked immunosorbent assay (FLISA), enzyme immunoassay (EIA), radioimmunoassay (RIA), electro-chemiluminescence immunoassay, chemiluminescence immunoassay, an immuno assay based ondetection of luminescence, fluorescence, chemiluminescence or electrochemiluminescence, immunoprecipitation assay, slot / blot assay, lateral flow assay, single molecule array, or agglutination.BRIEF DESCRIPTION OF THE DRAWINGS
[0022] For a more complete understanding of tire features and advantages of the present disclosure, reference is now made to the detailed description of the disclosure along with the accompanying figures and in which:
[0023] FIGS. 1 A to ID show a comparative analysis of fungal and bacterial ice-nucleating proteins. (FIG. 1 A) Schematic domain map of the INP sequences from M. alpina (MoINP). E. parvispora (EnINP). P. clonocytis (PoINP), and the bacterial Pseudomonas syringae (PsINP), highlighting conserved and variable regions. (FIG. IB, FIG. 1C) WebLogo plots of the first 33 and the last 7 sixteen-residue repeats in EnINP CRD, illustrating sequence conservation. Tire overall stack height reflects the degree of conservation, while individual letter heights represent the relative frequency of each amino acid at that position. (FIG. ID) AlphaFold3 models of MoINP, EnINP, PoINP, and PsINP with arrow s representing the characteristic [3-strands of the CRD. The models are colored by different domains and correspond to those shown in (FIG. 1A).
[0024] FIGS. 2A to 2C shows the AlphaFold3 model of A / / INP and cross-sections through the solenoid. (FIG.2 A) The model of EnINP is colored by different domains with arrows representing [3-strands. The model highlights a [3-solenoid fold (grey, purple) adjacent to the disulfide capping motif (orange). (FIG. 2B) Crosssection through the central domain region. Residues are identified by their one-letter codes. Boxes indicated the location of the characteristic TQT, SLT, and YGS motifs. (FIG. 2C) Cross-section of the central domain’s capping structure, where adjacent cysteine residues can form disulfide bonds that stabilize the [3-solenoid fold.
[0025] FIG. 3 shows the size determination of fungal ice nucleators (INs) from M. alpina upon filtration Cumulative number of INs per unit mass of AT. alpina (Nm) for extracts containing ice nucleators from spores and mycelial surfaces and samples that were passed through 50 kDa (yellow) MWCO filters.
[0026] FIGS. 4A to 4C shows freezing experiments with aqueous samples of fungal INs from M. alpina and E. parvispora. (FIG. 4A) Cumulative freezing spectra (number of INs per unit mass, Nm) measured for AT. alpina and E. parvispora. The lines represent the optimized solution obtained using the HUB-backward code, assuming that the differential spectra consist of two Gaussian subpopulations for M. alpina (blue line) and three Gaussian subpopulations for E. parvispora (dark red line) as shown in the next panel. (FIG. 4B) Differential freezing spectra (normalized distribution function, n;;i(T)) derived from (FIG. 4A) exhibiting modal freezing temperatures of —5.9 °C and -7.5 °C forArfoINPs and -5.6 °C, -6.5 °C, -7.5 °C for / j / INPs. (FIG. 4C) Ice nucleation temperatures predicted as a function of the number of aggregated INPs from M. alpina and E. parvispora based on Classical Nucleation Theory (CNT) as implemented in the HINT algorithm. Blue circles and red squares indicate the freezing temperatures of rectangular surfaces formed byparallel-aligned INP monomers, assuming an ice-binding surface of 3.4 nm width and a length of 25.3 nm for AfolNP (blue) and 19 nm for / . / / INP (red), based on AlphaFold3 structural predictions.
[0027] FIGS. 5A to 5C show INP assembly mechanism into functional aggregates. (FIG. 5A, 5B) Electrostatic surface map of the / '. / / INP monomer. Positively charged residues are shown in blue, negatively charged residues are shown in red, while the tyrosine ladder is shown in violet. (FIG. 5C) INP assembly mechanism into dimers, trimers, tetramers, and pentamers. Dimer formation is mediated by stacking of tyrosine ladders (violet areas) between adjacent monomers. The trimer, tetramer, and pentamer formation are likely enabled by electrostatic interactions between the outward-facing positively and negatively charged residues located on opposing ends of tire [3-solenoids with the assistance of the charged N-terminal linker.
[0028] FIG. 6 shows a sequence alignment of P INP, AfolNP, / '. / / INP. and PoINP. Residues with 100% conservation across all four INPs are highlighted in dark purple, while residues conserved in three of the four sequences are shown in light purple. Alignment was performed using the UniProt Align Tool.
[0029] FIG. 7 shows the ice nucleation activity of yeast strains expressing fungal INPs. The yeast Saccharomyces cerevisiae and water controls exhibit no freezing events between -6 °C and -12 °C. In contrast, yeast strains expressing AfolNP or / . / / INP show ice nucleation activity at temperatures above -12 °C. These results provide genetic evidence that the InaZ orthologues encoding AfolNP and / . / INP are sufficient to confer ice nucleation activity in yeast.
[0030] FIG. 8: Electrostatic surface maps of bacterial INP (P.sTNP) and fungal INPs (A / oINP, / '.7 / INP. and PoINP) highlighting differences in charge distribution. Positively charged residues (Lysine, Arginine, and Histidine) are shown in shades of blue, while negatively charged residues (Aspartic Acid and Glutamic Acid) are shown in red and orange, respectively. In PsINP, positively charged residues cluster near the C-terminus, while negatively charged residues are found near the N-terminus along one side of tire solenoid. In contrast, fungal INPs exhibit a more alternating charge arrangement along the solenoid, with a notable positively charged patch at the N-terminus. Additionally, fungal INPs incorporate higher histidine content, a feature largely absent in bacterial INPs. These differences suggest distinct assembly and functional mechanisms between bacterial and fungal INPs.
[0031] FIG. 9 shows an electrostatic surface maps of bacterial INP f / AINP) and fungal INPs (AfolNP, / '. / INP. and oINP) highlighting differences in charge distribution. Positively charged residues (Lysine, Arginine, and Histidine) are shown in shades of blue, while negatively charged residues (Aspartic Acid and Glutamic Acid) are shown in red and orange, respectively. In 7NINP, positively charged residues cluster near the C-terminus, while negatively charged residues are found near the N-terminus along one side of tire solenoid. In contrast, fungal INPs exhibit a more alternating charge arrangement along the solenoid, with a notable positively charged patch at the N-terminus. Additionally, fungal INPs incorporate higher histidine content, a featureBSL:2000WGlargely absent in bacterial INPs. These differences suggest distinct assembly and functional mechanisms between bacterial and fungal INPs.
[0032] FIG. 10 shows AlphaFold3 model of oINP and cross-sections through the solenoid. The model of PoINP is colored by different domains with arrows representing beta strands. Tire model highlights a p-solenoid fold (grey, purple) adjacent to the disulfide capping motif (orange). Cross-section through the central domain region. Residues are identified by their one letter codes. Boxes indicated the location of tire characteristic TQT, SLT, and YGS motifs. Cross-section of the central domain’s capping structures, where adjacent cysteine residues can fonn disulfide bonds that stabilize the -solenoid fold and prevent uncoiling.
[0033] FIG. 11 shows AlphaFold3 model of AfolNP and cross-sections through the solenoid. The model of AfolNP is colored by different domains with arrows representing beta strands. The model highlights a P-solenoid fold (grey, purple) adjacent to the disulfide capping motif (orange). Cross-section through the central domain region. Residues are identified by their one letter codes. Boxes indicated the location of tire characteristic TQT, SLT, and YGS motifs. Cross-section of the central domain’s capping structures, where adjacent cysteine residues can form disulfide bonds that stabilize the p-solenoid fold and prevent uncoiling.
[0034] FIGS. 12A to 12D show ice nucleating activity of yeast strains expressing fungal INpros. Ice nucleation activity of yeast strains expressing fungal INpros. (FIG. 12A) Fraction of ice (rice) and cumulative freezing spectra (FIG. 12B) for a serial dilution of S. cerevisiae expressing EnINpro. The presented / ice data corresponds to the Nrn plot shown in (FIG. 12B). (FIG. 12C) Fraction of ice (rice) and cumulative freezing spectra (FIG. 12D) for a serial dilution of S. cerevisiae expressing MoINpro. Tire presented ice data corresponds to the Nm plot shown in (FIG. 12C). Serial 10-fold dilutions were prepared from IN samples with optical densities of OD600= 0.9 at 600 nm, which corresponds to a concentration of ~ 1 mg / mL. Blue-shaded regions represent the freezing range of pure water in the setup (<-23°C).
[0035] FIGS. 13A to 13C show freezing experiments with aqueous samples of fungal Ins from A / , alpina and E. parvispora. (FIG. 13 A) Cumulative freezing spectra (number of INs per unit mass, Nm) measured for M. alpina and A. parvispora. The lines represent the optimized solution obtained using the HUB-backward code, assuming that the differential spectra consist of two Gaussian subpopulations for M. alpina (blue line) and three Gaussian subpopulations for E. parvispora (dark red line) as shown in the next panel. (FIG. 13B) Differential freezing spectra (normalized distribution function. n / w(T)) derived from (FIG. 13 A) exhibiting modal freezing temperatures of -5.9 °C and -7.5 °C forAfoINpros and -5.6 °C, -6.5 °C, -7.5 °C for / . / / INpros. (FIG. 13C) Ice nucleation temperatures predicted as a function of the number of aggregated INpros from M. alpina and E. parvispora based on Classical Nucleation Theory (CNT) as implemented in the HINT algorithm. Circles and squares indicate the freezing temperatures of rectangular surfaces formed by parallel-aligned INpro monomers, assuming an ice-binding surface of 3.4 nm width and a length of 25.3 nm for AfolNpro (top line) and 19 nm for A / zINpro (bottom line), based on AlphaFold3 structural predictions.
[0036] FIGS. 14A and 14B show the predicted structures of the fungal A oINP (FIG. 14A) and the bacterial .vINP (FIG. 14B) colored according to functional domains. For AfolNP the N-terminal domain (blue) is followed by the central [3-solenoid repeat domain (grey) and the disulfide capping motifs are highlighted in yellow. For / A IN P the N-terminal domain (blue) is followed by the central repeat domain (grey) and the charge C-terminal capping domain (red).
[0037] FIGS. 15A to 15D show the structural and functional effects of disulfide reduction on INPs. Freezing experiments of aqueous solutions of fungal INs from E. parvispora (FIG. 15A) and bacterial INs from P. syringae (FIG. 15B) in water (upper diamonds grey) and in tire presence of 100 mM DTT (lower diamonds). Shown are tire cumulative number of INs (Nm) per unit mass of INs vs temperature. Hie insets show crosssection of the C-terminal region of the fungal AfolNP and bacterial / AINP. AfolNP has cysteine residues that can form stabilizing disulfide bonds, whereas / AINP has a charged C-terminal capping domain and only a single cysteine residue. (FIG. 15C) Cumulative number of INs and Tso values at the highest concentration in water and in 100 mM DTT, where Tso is defined as the temperature at which 50% of droplets froze. Error bars represent the standard deviation betw een individual measurements. (FIG. 15D) CD spectra of AfoINPs in water (dark circles) and in the presence of 20 mM TCEP (light circles), indicating structural changes.
[0038] FIGS. 16A to 16C show freezing experiments of aqueous buffered solutions of (FIG. 16A) fungal INs from E. parvispora and (FIG. 16B) bacterial INs from P. syringae at different pH values. Shown are the cumulative number of INs (Nm) per unit mass of INs vs temperature. (FIG. 16C) Cumulative number of bacterial and fungal INs and Tso values at the highest concentration as a function of pH, where Tso is defined as the temperature at which 50% of droplets froze. Error bars represent the standard deviation between individual measurements.
[0039] FIGS. 17A to 17C show the cumulative freezing spectra of bacterial and fungal IN that were subjected to temperatures ranging from 20 °C to 90 °C prior to ice nucleation measurements. FIG. 17A shows that fungal INs at 20 °C exhibit an increase — 6 °C, followed by a plateau at lower temperatures. FIG. 17B shows that bacterial INs at 20 °C display two distinct increases in Nmat —3 °C and —7 °C. FIG. 17C summarizes the cumulative Nmvalues and T50at the highest concentration as a function of temperature.DETAILED DESCRIPTION
[0040] While the making and using of various aspects of the present disclosure are discussed in detail below, it should be appreciated that the present disclosure provides many applicable inventive concepts that can beBSU:2000WGembodied in a wide variety of specific contexts. The specific aspects discussed herein are merely illustrative of specific ways to make and use the disclosure and do not delimit the scope of the disclosure.
[0041] To facilitate the understanding of this disclosure, a number of terms are defined below. Terms defined herein have meanings as commonly understood by a person of ordinary’ skill in the areas relevant to the present disclosure. Terms such as "a", “an” and ‘‘the” are not intended to refer to only a singular entity, but include the general class of which a specific example may be used for illustration. The terminology herein is used to describe specific aspects of the disclosure, but their usage does not delimit the disclosure, except as outlined in the claims.
[0042] In the specification, reference may be made to the spatial relationships between various components and to the spatial orientation of various aspects of components as the devices are depicted in the attached drawings. How ever, as will be recognized by those skilled in the art after a complete reading of the present application, the devices, members, apparatuses, etc. described herein may be positioned in any desired orientation. Thus, the use of terms such as “above,” “below.” “upper,” “lower,” or other like terms to describe a spatial relationship between various components or to describe the spatial orientation of aspects of such components should be understood to describe a relative relationship between the components or a spatial orientation of aspects of such components, respectively, as the device described herein may be oriented in any desired direction.
[0043] The novel fungal ice nucleating proteins (INPs) are cell-free, extremely stable, resistant to pH, warm temperatures and membrane fluidizers. Unlike bacterial INPs, which require intact membranes for functionality. This allows for a clean, regulatory-compliant alternative that achieves similar ice nucleation efficiency without tire need for whole bacteria or bacterial fragments. Uris is particularly advantageous for food and medical applications, where purity and safety are critical, as well as for artificial snowmaking, where bacterial -based INPs are restricted in regions like Europe, while purified proteins would be permitted.
[0044] Unlike bacterial INPs, the genetic and molecular basis of ice formation in other organisms is largely unknown. However, several widely distributed fungi and lichen species exhibit highly efficient and exceptionally stable ice-nucleating activity5,6,9,20 that enables freezing above -5 °C. These INs function independent of cell membranes20, withstand extreme pH conditions (2-12)21, and have been confirmed as proteinaceous through circular dichroism and their sensitivity to proteolytic digestion and heat denaturation9.22. Size characterization experiments show fungal INPs are smaller than bacterial INPs and nucleate ice through a fundamentally distinct, non-membrane-bound mechanism5,9,22.
[0045] Here, the inventors examine the genetic basis, composition, and structure of these potent biological INs to elucidate the molecular determinants of their size, stability, and supramolecular aggregation mechanisms that drive their remarkable ice-nucleating activity.
[0046] As used herein, the term “nucleic acid” refers to polynucleotides or oligonucleotides such as deoxyribonucleic acid (DNA), and, where appropriate, ribonucleic acid (RNA). The term should also be understood to include, as equivalents, analogs of either RNA or DNA made from nucleotide analogs and as applicable to the embodiment being described, single (sense or antisense) and double-stranded polynucleotides.
[0047] As used herein, the tenns “protein”, “polypeptide” or “peptide” refer to compounds comprising amino acids joined via peptide bonds and are used interchangeably.
[0048] As used herein, the term ice-nucleating protein (INP) refers to proteins that facilitate the nucleation of water into ice at or below 0° Celsius. Often, INP will facilitate nucleation of ice at -1, -2, -3, -4, -5 Celsius, or lower temperatures. INPs will also capture water and can be used to capture and release water under different circumstances, for example by lower the ambient temperature at or below freezing water can be captured, and then released by increasing the temperature above freezing.
[0049] As used herein, the term “central repeating domain (CRD)” refers to a portion of an ice-nucleating protein that includes tandem repeat motifs that adopts a [3-solenoid fold. Generally, the CRD will include the central repeat domains of ice nucleating proteins and have at least 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, or 100% sequence identity to the CRD of SEQ ID NO: 1. 2. 3, or 12. The CRD comprises a plurality of 16-amino acid repeat motifs with a consensus sequence TA(G / T)(S / T)Xn(SEQ ID NO:5). In non-limiting examples, the CRDs can be from Mortierella sp., Entomortierella sp., Podilci sp., Gryganskiella sp., or from related fungi in the class of the Mortierellomycetes.
[0050] As used herein, the terms “N-terminal flanking peptide” or “C-terminal flanking peptide” that comprises at least one pair of cysteine residues spaced apart by no more than about 15 amino acids refers to a peptide that is added amino- or carboxy-, respectively, from the CRD and is capable of forming intramolecular disulfide bonds that stabilize the 0-solenoid fold of the CRD. The '‘N-terminal flanking peptide” and / or “C- terminal flanking peptide” stabilize the CRD such that the INP does not require a transmembrane domain and a cell membrane or cell wall to be stabilized. As such, the “N-terminal flanking peptide” or “C-terminal flanking peptide” can be added to non-fimgal INPs to stabilize the CRD. In one example, the N-terminal flanking peptide, the C-terminal flanking peptide, or both, are no more than about 20 amino acids from the CRD and are conserved to have at least 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, or 100% sequence identity with one or more flanking cysteine-rich peptides of INPs from Mortierella alpina. Entomortierella parvispora, or Podila clonocystis of SEQ ID NOS: 1, 2, 3, or 12, respectively. The CRDs are expressed as monomers, but can be formed into dimers, trimers, tetramers, etc., but a process of self-assembly.
[0051] The INPs disclosed herein have several important features, including: (1) the fungal INP work cell- free, (2) are extremely potent (operate at picomolar concentrations), and (3) are extremely stable in solution(unlike bacterial INP) even in pH ranges 2-12 or in the presence of detergents, or temperature fluctuations. Since they are pure formulations (cell free), the INPs can be used in food and biomedical applications.
[0052] Tire INPs disclosed herein, will have utility in various applications. These include the following.
[0053] (1) Cry opreservation and Biomedicine. The INPs can be used for controlled ice formation in cryoprcscrvation of cells, tissues, and organs, enabling higher viability during thawing by avoiding intracellular freezing. The INPs can also be used as an additive in low-DMSO or DMSO-free formulations to initiate extracellular ice at warmer subzero temperatures, reducing toxic cryoprotectant loads.
[0054] (2) Agriculture and Frost Protection. Tire INPs can be used for frost-hardening treatments for crops using non-living fungal INPs to precondition plants to subzero temperatures in a controlled, non-infectious way. The INPs can also be used to improved field frost sensors using immobilized fungal INPs as precise, protein-based nucleators to detect freezing thresholds.
[0055] (3) Weather Modification and Snowmaking. Tire INPs can be used as an additive for artificial snow production, similar to SNOMAX®, but without bacterial contaminants or biosafety concerns. Tire INPs can be used as a seeding agent in cloud microphysics experiments or geoengineering, offering high nucleation activity without membrane dependency.
[0056] (4) Food and Cold Chain Technology. The INPs can be used as ice-structuring additives in frozen foods for texture optimization (e.g., creamy ice cream, less icy vegetables). The INPs can be used in cold chain sensors that trigger detectable changes when freezing occurs, powered by immobilized fungal INPs.
[0057] (5) High-throughput Freezing Assays. The INPs can be used as standardized icc nucleators in droplet freezing assays or freeze / thaw screens, with tunable activity and consistent batch-to-batch behavior. Hie INPs can also be used as or in calibration tools for instruments like droplet freezing arrays or Raman-based freezing monitors.
[0058] (6) Materials Science & Engineering Applications of Fungal INPs. The INPs can be used as ice-templated materials (freeze casting). The fungal INPs to control pore structure and alignment in freeze-cast ceramics, polymers, or composite scaffolds. The INPs can also be used to enable spatially patterned ice growth for bioinspired materials with anisotropic mechanical or transport properties.
[0059] As used herein, the term “fusion protein” refers to a hybrid protein, that includes portions of two or more different polypeptides, or fragments thereof, resulting from the expression of a polynucleotide that encodes at least a portion of each of the two polypeptides. Tire INP fusion proteins of the present invention, by being stabilized at the N-Terminus, the C-terminus, or both, are able to be secreted from the cell expressing the INP. Generally, the INPs herein do not include a transmembrane domain as a result of stabilizing the CRD. but in some examples a transmembrane domain can be added to the fusion protein.BSU:2000WG
[0060] As used herein, the term “tag” refers to a peptide sequences that is part of a fusion protein or can be attached chemically to tire INPs of tire present invention. Examples of peptide tags include but are not limited to: His-tag, a FLAG-tag. aHA-tag, a Strep-tag, a Strep-II tag, a C9-tag, a glutathione S-transferase tag, HiBiT tag, a maltose-binding protein tag, a T7 tag, a V5 tag. an S tag, a SUMO tag, a TAP tag, a TRX tag, a calmodulin binding peptide, a chitin binding domain, a cellulose binding domain, a E2 epitope, a HaloTag. a HSV tag. a HBH tag, a KT3 tag, or a myc-tag.
[0061] As used herein, the term “gene” refers to a functional protein, polypeptide or peptide-encoding unit. As will be understood by those in tire art, this functional term includes both genomic sequences, cDNA sequences, or fragments or combinations thereof, as well as gene products, including those that may have been altered by the hand of man. Purified genes, nucleic acids, protein and the like are used to refer to these entities when identified and separated from at least one contaminating nucleic acid or protein with which it is ordinarily associated. The term “sequences” as used herein is used to refer to nucleotides or amino acids, whether natural or artificial, e.g., modified nucleic acids or amino acids. When describing “transcribed nucleic acids” those sequence regions located adjacent to the coding region on both the 5’, and 3’, ends such that the deoxyribonucleotide sequence corresponds to the length of the full-length rnRNA for the protein as included. Tire term “gene” encompasses both cDNA and genomic forms of a gene. A gene may produce multiple RNA species that are generated by differential splicing of the primary RNA transcript. cDNAs that are splice variants of the same gene will contain regions of sequence identity or complete homology (representing the presence of the same exon or portion of the same exon on both cDNAs) and regions of complete non-identity (for example, representing the presence of exon “A” on cDNA I wherein cDNA 2 contains exon “B” instead). Because the two cDNAs contain regions of sequence identity they will both hybridize to a probe derived from the entire gene or portions of the gene containing sequences found on both cDNAs; the two splice variants are therefore substantially homologous to such a probe and to each other.
[0062] As used herein, the term “vector” is used in reference to nucleic acid molecules that transfer DNA segment(s) from one cell to another. The vector may be further defined as one designed to propagate specific sequences, or as an expression vector that includes a promoter operatively linked to the specific sequence, or one designed to cause such a promoter to be introduced. The vector may exist in a state independent of the host cell chromosome, or may be integrated into the host cell chromosome
[0063] As used herein, the term “host cell” refers to cells that have been engineered to contain nucleic acid segments or altered segments, whether archeal, prokaryotic, or eukaryotic. Thus, engineered, or recombinant cells, arc distinguishable from naturally occurring cells that do not contain rccombinantly introduced genes through the hand of man.
[0064] A polynucleotide sequence that is “substantially homologous” to the icc-nuclcating proteins (INPs) or portions thereof, of SEQ ID N0:X” is defined herein as an oligonucleotide sequence that exhibits greater thanor equal to 75% identity to the sequence of SEQ ID NO: 1 when sequences having a length of 100 bp or larger are compared.
[0065] As used herein, the term “altered”, or “alterations” or “modified” with reference to nucleic acid or polypeptide sequences is meant to include changes such as insertions, deletions, substitutions, fusions with related or unrelated sequences, such as might occur by the hand of man, or those that may occur naturally such as polymorphisms, alleles and other structural types. Alterations encompass genomic DNA and RNA sequences that may differ with respect to their hybridization properties using a given hybridization probe. Alterations of polynucleotide sequences for ice -nucleating proteins or portions thereof, or fragments thereof, include those that increase, decrease, or have no effect on functionality. Alterations of polypeptides refer to those that have been changed by recombinant DNA engineering, chemical, or biochemical modifications, such as amino acid derivatives or conjugates, or post-translational modifications.
[0066] As used herein, the phrase “ice-nucleating protein expressing nucleic acid” is either DNA, RNA, single -stranded or double -stranded and any chemical modifications thereof that are capable of expressing an ice-nucleating protein. Modifications include, but are not limited to, those that provide other chemical groups that incorporate additional charge, polarizability', hydrogen bonding, electrostatic interaction, and fluxionality to the individual nucleic acid bases or to the nucleic acid as a whole.
[0067] A sample is any mixture of macromolecules obtained from a person. This includes, but is not limited to, blood, plasma, urine, semen, saliva, lymph fluid, meningeal fluid, amniotic fluid, glandular fluid, and cerebrospinal fluid. This also includes experimentally separated fractions of all of the preceding. “Sample” also includes solutions or mixtures containing homogenized solid material, such as feces, cells, tissues, and biopsy samples. Samples herein include one or more that are obtained at any point in time, including diagnosis, prognosis, and periodic monitoring.
[0068] The terms “a sequence essentially as set forth in SEQ ID NO. (#)”, “a sequence similar to”, “nucleotide sequence” and similar terms, with respect to nucleotides or amino acids, refers to sequences that substantially correspond to any portion of the sequence identified herein as SEQ ID NO.: X. These terms refer to synthetic as well as naturally-derived molecules and includes sequences that possess biologically, immunologically, experimentally, or otherwise functionally equivalent activity, for instance with respect to hybridization by nucleic acid segments, or the ability to encode all or portions of the INPs. Naturally, these terms are meant to include information in such a sequence as specified by its linear order.
[0069] As used herein, the tenn “sequence identity” refers to the extent to which two optimally aligned polynucleotide or amino acid sequences are invariant throughout a window of alignment of components, e.g.. nucleotides or amino acids. Thus, the “identity” can be readily calculated by known methods including, but not limited to, those described in: Computational Molecular Biology (Lesk, A. M., ed.) Oxford University' Press, New York (1988); Biocomputing: Informatics and Genome Projects (Smith, D. W., ed.) Academic Press,New York (1993); Computer Analysis of Sequence Data, Part I (Griffin, A. M., and Griffin, H. G., eds.) Humana Press, New Jersey (1994); Sequence Analysis in Molecular Biology (von Heinje, G., ed.) Academic Press (1987); and Sequence Analysis Primer (Gribskov, M. and Devereux, J., eds.) Stockton Press, New York (1991), relevant portions incorporated herein by reference.
[0070] As used herein, the term “percent sequence identity” or “percent identity” refers to the percentage of identical nucleotides in a linear polynucleotide sequence of a reference (“query”) polynucleotide molecule (or its complementary strand) as compared to a test (“subject”) polynucleotide molecule (or its complementary strand) when the two sequences are optimally aligned. Likewise, the same applies to amino acid sequences of peptides or proteins. As such, “percent identity” also refers to the percentage of identical amino acids in an amino acid sequence.
[0071] For sequence comparison, typically one sequence acts as a reference sequence to which test sequences are compared. When using a sequence comparison algorithm, test and reference sequences are entered into a computer, subsequence coordinates are designated if necessary, and sequence algorithm program parameters are designated. The sequence comparison algorithm then calculates the percent sequence identity for the test sequence(s) relative to the reference sequence, based on the designated program parameters.
[0072] Optimal alignment of sequences for aligning a comparison window are well known to those skilled in the art and may be conducted by tools such as the local homology algorithm of Smith and Waterman, the homology alignment algorithm of Needleman and Wunsch, the search for similarity method of Pearson and Lipman, and optionally by computerized implementations of these algorithms such as GAP, BESTFIT, FASTA, and TFASTA available as part of the GCG® Wisconsin Package® (Accelrys Inc., San Diego, CA). For example, an “identity fraction” for aligned segments of a test sequence and a reference sequence is the number of identical components that are shared by the two aligned sequences divided by the total number of components in the reference sequence segment, i.e ., the entire reference sequence or a smaller defined part of the reference sequence. Percent sequence identity is represented as the identity fraction multiplied by 100. The comparison of one or more polynucleotide sequences may be to a full-length polynucleotide sequence or a portion thereof, or to a longer polynucleotide sequence. For purposes of this invention “percent identity.” may also be determined using BLASTX version 2.0 for translated nucleotide sequences and BLASTN version 2.0 for polynucleotide sequences.
[0073] In addition to calculating percent sequence identity, the BLAST algorithm also performs a statistical analysis of the similarity between two sequences (see, e.g., Karlin & AltschuL Proc. Nat’l. Acad. Sci. USA 90:5873-5787 (1993)). One measure of similarity provided by the BLAST algorithm is the smallest sum probability (P(N)), which provides an indication of the probability by which a match between two nucleotide or amino acid sequences would occur by chance. For example, atest nucleic acid sequence is considered similar to a reference sequence if the smallest sum probability in a comparison of the test nucleotide sequence to thereference nucleotide sequence is less than about 0.1 to less than about 0.001. Thus, in some embodiments of the invention, the smallest sum probability in a comparison of the test nucleotide sequence to tire reference nucleotide sequence is less than about 0.001.
[0074] As used herein, the term “homologous” may also be used to refer to the relationship of a first gene to a second gene by descent from a common ancestral DNA sequence. In such instances, the term “homolog” indicates a relationship between genes separated by the event of speciation (or an “ortholog”) or to the relationship between genes separated by the event of genetic duplication (or a “paralog”). In other instances, “homologous” may be used to refer to the level of sequence identity between one or more polynucleotide sequences, in such instances the one or more polynucleotide sequences do not necessarily descend from a common ancestral DNA sequence. Those with skill in the art are aware of the interchangeably of the term “homologous” and appreciate the proper application of the term.
[0075] For polynucleotides, the inhibition of hybridization of the completely complementary sequence to the target sequence may also be examined using a hybridization assay involving a solid support (e.g., Southern or Northern blot, solution hybridization and the like) under conditions of low stringency. Low stringency conditions may be used to identify the binding of two sequences to one another while still being specific (i.e., selective). The absence of non-specific binding may be tested by the use of a second target that lacks even a partial degree of complementarity (e.g., less than about 30% identity). In the absence of non-specific binding, the probe will not hybridize to the second non-complementary target and the original interaction w ill be found to be selective. Low stringency conditions are generally conditions equivalent to binding or hybridization at 42 degrees Centigrade in a solution consisting of 5XSSPE (43.8 g / 1 NaCl, 6.9 g / 1 NaFhPCh-FbO and 1.85 g / 1 EDTA, pH 7.4), 0.1% SDS, 5X Denhardt’s reagent (50X Denhardt’s contains per 500 ml: 5 g Ficoll (Type 400, Pharmacia), 5 g BSA (Fraction V; Sigma) and 100 micrograms / ml denatured salmon sperm DNA); followed by washing in a solution comprising 5X SSPE, 0.1% SDS at 42 degrees Centigrade when a probe of about 500 nucleotides in length is employed. Hie art knows that numerous equivalent conditions may be employed to achieve low stringency conditions. Factors that affect the level of stringency include: the length and nature (DNA, RNA, base composition) of the probe and nature of the target (DNA, RNA, base composition, present in solution or immobilized, etc.) and the concentration of the salts and other components (e.g., formamide, dextran sulfate, polyethylene glycol). Likewise, the hybridization solution may be varied to generate conditions of low stringency hybridization different from, but equivalent to, the above listed conditions. In addition, the art knows conditions that promote hybridization under conditions of high stringency (e.g., increasing the temperature of the hybridization and / or wash steps, inclusion of formamide, etc.).
[0076] As used herein, the term “control sequences” refers to DNA sequences necessary for the expression of an operably linked coding sequence in a particular host organism. The control sequences that are suitable forBSU:2000WGprokaryotes, for example, include a promoter, optionally an operator sequence, a ribosome binding site, and transcriptional terminators. Highly regulated inducible promoters that suppress Fab’ polypeptide synthesis at levels below growth-inhibitory amounts while the cell culture is growing and maturing, for example, during the log phase may be used.
[0077] As used herein, a nucleic acid is “operably linked" w hen it is placed into a functional relationship with another nucleic acid sequence. For example, DNA for a presequence or secretory leader is operably linked to DNA for a polypeptide if it is expressed as a preprotein that participates in the secretion of the polypeptide; a promoter or enhancer is operably linked to a coding sequence if it effects the transcription of the sequence; or a ribosome binding site is operably linked to e coding sequence if it is positioned so as to facilitate translation. Generally, “operably linked” refers to a DNA sequences being linked are contiguous and, in the case of a secretory leader, contiguous and in same reading frame. Enhancers do not have to be contiguous. Linking is accomplished by ligation at convenient restriction sites. If such sites do not exist, then synthetic oligonucleotide adaptors or linkers are used in accord with conventional practice.
[0078] As used herein, an “exogenous” element is defined herein to mean a nucleic acid sequence that is foreign to the cell, or homologous to the cell but in a position within the host cell nucleic acid in which the element is ordinarily not found.
[0079] As used herein, the expressions “cell” and “cell culture” are used interchangeably end all such designations include progeny. Thus, the words “transformants” and “transformed cells” include the primary subject cell and cultures derived therefrom without regard for the number of transfers. It is also understood that all progeny may not be precisely identical in DNA content, due to deliberate or inadvertent mutations. Mutant progeny that have the same function or biological activity as screened for in the originally transformed cell are included. Different designations are will be clear from the contextually clear.
[0080] As used herein, “plasmids” are designated by a low er case p preceded and / or followed by capital letters and / or numbers. The starting plasmids herein are commercially available, are publicly available on an unrestricted basis, or can be constructed from such available plasmids in accord with published procedures. In addition, other equivalent plasmids are known in the art and will be apparent to the ordinary artisan.
[0081] As used herein, “recovery” or “isolation” of a given fragment of DNA from a restriction digest refers to the separation of the digest on polyacrylamide or agarose gel by electrophoresis, identification of the fragment of interest by comparison of its mobility versus that of marker DNA fragments of known molecular weight, removal of the gel section containing the desired fragment, and separation of the gel from DNA. This procedure is known generally. For example, see Lawn et al. (Nucleic Acids Res. 1981. 9:6103-6114), and Goeddel et al. (Nucleic Acids Res. 1980. 8:4057).
[0082] As used herein, the term “preparation” when referring to DNA from cells refers to tire isolation of a plasmid DNA from a culture of the host cells. Methods used commonly for DNA preparation are the large and small-scale plasmid preparations described in sections 1.25-1.33 of Sambrook et al., (Molecular Cloning: A Laboratory Manual New York: Cold Spring Harbor Laboratory Press, 1989). DNA preparations are purified by methods well known in the art (see section 1.40 of Sambrook et al., supra).
[0083] As used herein, the term “endogenous” refers to a substance the source of which is from within a cell. Endogenous substances are produced by the metabolic activity of a cell. Endogenous substances, however, may nevertheless be produced as a result of manipulation of cellular metabolism to, for example, make the cell express the gene encoding tire substance.
[0084] As used herein, the term “exogenous” refers to a substance tire source of which is external to a cell. An exogenous substance may nevertheless be internalized by a cell by any one of a variety of metabolic or induced means known to those skilled in the art.
[0085] A genomic form or clone of a gene contains tire coding region interrupted with non-coding sequences termed “introns” or “intervening regions” or “intervening sequences.” Introns are segments of a gene which are transcribed into nuclear RNA (hnRNA): introns may contain regulatory elements such as enhancers. Introns are removed, excised or “spliced out” from the nuclear or primary transcript: introns therefore are absent in the messenger RNA (mRNA) transcript. The mRNA functions during translation to specify the sequence or order of amino acids in a nascent polypeptide.
[0086] In addition to containing introns, genomic forms of a gene may also include sequences located on both the 5’ and 3’ end of the sequences which are present on tire RNA transcript. These sequences are referred to as “flanking” sequences or regions (these flanking sequences are located 5’ or 3’ to the non-translated sequences present on the mRNA transcript). Tire 5’ flanking region may contain regulatory sequences such as promoters and enhancers that control or influence the transcription of the gene. The 3' flanking region may contain sequences that direct the termination of transcription, post-transcriptional cleavage and polyadenylation.
[0087] DNA molecules are said to have “5 ’ ends” and “3 ’ ends” because mononucleotides are reacted to make oligonucleotides in a manner such that the 5’ phosphate of one mononucleotide pentose ring is attached to the 3’ oxygen of its neighbor in one direction via a phosphodiester linkage. Therefore, an end of an oligonucleotides referred to as the “5 ’ end” if its 5 ’ phosphate is not linked to the 3 ’ oxygen of a mononucleotide pentose ring and as the “3 ' end” if its 3 ’ oxygen is not linked to a 5 ’ phosphate of a subsequent mononucleotide pentose ring. As used herein, a nucleic acid sequence, even if internal to a larger oligonucleotide, also may be said to have 5’ and 3’ ends. In either a linear or circular DNA molecule, discrete elements are referred to as being “upstream” or 5 ’ of the “downstream” or 3 ’ elements. This terminology reflects the fact that transcription proceeds in a 5’ to 3’ fashion along the DNA strand.
[0088] As used herein, the term “hybridize” refers to any process by which a strand of nucleic acid binds with a complementary strand through base pairing. Hybridization and the strength of hybridization (i. e. , tire strength of the association between the nucleic acid strands) is impacted by such factors as the degree of complementary between the nucleic acids, stringency of the conditions involved, the melting temperature of the formed hybrid, and the G:C (or U:C for RNA) ratio within the nucleic acids.
[0089] As used herein, the terms “complementary” or “complementarity” refer to the natural binding of polynucleotides under permissive salt and temperature conditions by base-pairing. For example, for the sequence “A-G-T” binds to the complementary sequence “T-C-A”. Complementarity between two singlestranded molecules may be partial, in which only some of the nucleic acids bind, or it may be complete when total complementarity exists between the single stranded molecules. The degree of complementarity between nucleic acid strands has significant effects on the efficiency and strength of hybridization between nucleic acid strands. This is of particular importance in amplification reactions, which depend upon binding between nucleic acids strands.
[0090] As used herein, the term “homology,” refers to a degree of complementarity. There may be partial homology or complete homology ( / . ?., identity). A partially complementary' sequence is one that at least partially inhibits an identical sequence from hybridizing to a target nucleic acid; it is referred to using the functional term “substantially homologous.” The inhibition of hybridization of the completely complementary sequence to the target sequence may be examined using a hybridization assay (Southern or Northern blot, solution hybridization and the like) under conditions of low stringency. A substantially homologous sequence or probe will compete for and inhibit the binding ( / '. e. , the hybridization) of a completely homologous sequence or probe to the target sequence under conditions of low stringency. This is not to say that conditions of low stringency are such that non-specific binding is permitted; low stringency conditions require that the binding of two sequences to one another be a specific (z. e. , selective) interaction. The absence of non-specific binding may be tested by the use of a second target sequence which lacks even a partial degree of complementarity (e.g., less than about 30% identity); in the absence of non-specific binding, the probe will not hybridize to the second non-complementary target sequence.
[0091] When used in reference to a single-stranded nucleic acid sequence, the term “substantially homologous” refers to any probe that hybridizes (i.e., it is the complement of) to a single-stranded nucleic acid sequence under conditions of low, medium or high stringency as is well-known to the skilled artisan. As known in the art, numerous equivalent conditions may be employed to comprise either low or high stringency conditions. Factors that affect binding specificity include the length and nature (DNA, RNA, base composition) of the sequence, nature of the target (DNA, RNA, base composition, presence in solution or immobilization, etc.), and the concentration of the salts and other components (e.g. , the presence or absence of formamide, dextran sulfate and / or polyethylene glycol) are considered and the hybridization solution may bevaried to generate conditions of either low or high stringency different from, but equivalent to, the above listed conditions.
[0092] As used herein, the term “stringency” is used in reference to the conditions of temperature, ionic strength, and the presence of other compounds such as organic solvents, under which nucleic acid hybridizations are conducted. With “high stringency” conditions, nucleic acid base pairing will occur only between nucleic acid fragments that have a high frequency of complementary base sequences. Thus, conditions of “weak” or “low” stringency are often required with nucleic acids that are derived from organisms that are genetically diverse, as the frequency of complementary sequences is usually less. Low stringency conditions comprise conditions equivalent to binding or hybridization at 42° C in a solution consisting of 5X SSPE (43.8 g / 1 NaCl, 6.9 g / 1 NaH2PO4-H20 and 1.85 g / 1 EDTA, pH adjusted to 7.4 with NaOH), 0.1% SDS, 5X Denhardt's reagent (50X Denhardt’s contains per 500 ml: 5 g Ficoll (Type 400, Pharmacia), 5 g BSA [Fraction V; Sigma]) and 100 pg / ml denatured salmon sperm DNA) followed by washing in a solution comprising 5X SSPE, 01% SDS at 42°C when a probe of about 500 nucleotides in length is employed. High stringency conditions comprise conditions equivalent to binding or hybridization at 65°C in a solution consisting of 5X SSPE (43.8 g / 1 NaCl, 6.9 g / 1 NaH2PO4H20 and 1.85 g / 1 EDTA, pH adjusted to 7.4 with NaOH), 0.1% SDS, 5X Denhardt’s reagent (50X Denhardt’s contains per 500 ml: 5 g Ficoll (Type 400, Pharmacia), 5 g BSA [Fraction V; Sigma]) and 100 pg / ml denatured salmon sperm DNA) followed by washing in a solution comprising 5X SSPE, 01% SDS at 65°C when a probe of about 500 nucleotides in length is employed. Numerous equivalent conditions may be employed to comprise low stringency conditions: factors such as the length and nature (DNA, RNA. base composition) of the probe and nature of the target (DNA, RNA, base composition, present in solution or immobilized, etc.) and the concentration of the salts and other components (e g., the presence or absence of formamide, dextran sulfate, polyethylene glycol) are considered and the hybridization solution may be varied to generate conditions of low stringency hybridization different from, but equivalent to, the above listed conditions. In addition, the art knows conditions which promote hybridization under conditions of high stringency (e.g., increasing the temperature of the hybridization and / or wash steps, the use of formamide in the hybridization solution, etc.).
[0093] As used herein, the term “transformation,” refers to a process by which exogenous DNA enters and changes a recipient cell. It may occur under natural or artificial conditions using various methods well known in the art. Transformation may rely on any known method for the insertion of foreign nucleic acid sequences into a prokaryotic or eukaryotic host cell. Tire method is selected based on the host cell being transformed and may include, but is not limited to, viral infection, electroporation, lipofection, and particle bombardment. Such “transformed” cells include stably transfonned cells in which the inserted DNA is capable of replication either as an autonomously replicating plasmid or as part of the host chromosome.
[0094] As used herein, the term “transfection” refers to the introduction of foreign DNA into eukary otic cells. Transfection may be accomplished by a variety of methods known to the art including, e.g., calcium phosphate-DNA co-precipitation, DEAE-dextran-mediated transfection, polybrene-mediated transfection, electroporation, microinjection, liposome fusion, lipofection, protoplast fusion, retroviral infection, and biolistics. Thus, the term “stable transfection” or “stably transfected” refers to the introduction and integration of foreign DNA into the genome of the transfected cell. The term “stable transfectant” refers to a cell that has stably integrated foreign DNA into the genomic DNA. The term also encompasses cells that transiently express the inserted DNA or RNA for limited periods of time. Tirus, the temr “transient transfection” or “transiently- transfected” refers to tire introduction of foreign DNA into a cell where the foreign DNA fails to integrate into the genome of the transfected cell. The foreign DNA persists in the nucleus of the transfected cell for several days. During this time the foreign DNA is subject to the regulatory controls that govern the expression of endogenous genes in the chromosomes. The term “transient transfectant” refers to cells that have taken up foreign DNA but have failed to integrate this DNA.
[0095] As used herein, the term “selectable marker” refers to the use of a gene that encodes an enzymatic activity and which confers the ability to grow in medium lacking what would otherwise be an essential nutrient (e.g., the HIS3 gene in yeast cells); in addition, a selectable marker may confer resistance to an antibiotic or drug upon the cell in which the selectable marker is expressed. A review of the use of selectable markers in mammalian cell lines is provided in Sambrook, J., et al., MOLECULAR CLONING: ALABORATORY MANUAL, 2nd ed., Cold Spring Elarbor Laboratory' Press, New York (1989) pp.16.9-16.15.
[0096] As used herein, the term “reporter gene” refers to a gene that is expressed in a cell upon satisfaction of one or more contingencies and which, upon expression, confers a detectable phenotype to the cell to indicate that the contingencies for expression have been satisfied. For example, the gene for Luciferase confers a luminescent phenotype to a cell when the gene is expressed inside the cell. In the present invention, the gene for Luciferase may be used as a reporter gene such that the gene is only expressed upon the splicing out of an intron in response to an effector. Those cells in which the effector activates splicing of the intron will express Luciferase and will glow.
[0097] As used herein, the term “vector” refers to nucleic acid molecules that transfer DNA segment(s) from one cell to another. The term “vehicle” is sometimes used interchangeably with “vector.” The term “vector” as used herein also includes expression vectors in reference to a recombinant DNA molecule containing a desired coding sequence and appropriate nucleic acid sequences necessary' for the expression of the operably-linked coding sequence in a particular host organism. Nucleic acid sequences necessary for expression in prokaryotes usually include a promoter, an operator (optional), and a ribosome binding site, often along with other sequences. Eukaryotic cells are known to utilize promoters, enhancers, and termination and poly adenylation signals.
[0098] As used herein, the term “amplify’’, when used in reference to nucleic acids refers to the production of a large number of copies of a nucleic acid sequence by any method known in the art. Amplification is a special case of nucleic acid replication involving template specificity. Template specificity is frequently described in terms of “target” specificity. Target sequences are “targets” in the sense that they are sought to be sorted out from other nucleic acid. Amplification techniques have been designed primarily for this sorting out.
[0099] As used herein, the term “primer” refers to an oligonucleotide, whether occurring naturally as in a purified restriction digest or produced synthetically, which is capable of acting as a point of initiation of synthesis when placed under conditions in which synthesis of a primer extension product which is complementary to a nucleic acid strand is induced, (i.e., in the presence of nucleotides and an inducing agent such as DNA polymerase and at a suitable temperature and pH). The primer may be single stranded for maximum efficiency in amplification but may alternatively be double stranded. If double stranded, the primer is first treated to separate its strands before being used to prepare extension products. The primer must be sufficiently long to prime the synthesis of extension products in the presence of the inducing agent. The exact lengths of the primers will depend on many factors, including temperature, source of primer and tire use of the method.
[0100] As used herein, the term “probe” refers to an oligonucleotide ( / . e. , a sequence of nucleotides), whether occurring naturally as in a purified restriction digest or produced synthetically, recombinantly or by PCR amplification, which is capable of hybridizing to another oligonucleotide of interest. A probe may be singlestranded or double-stranded. Probes are useful in the detection, identification and isolation of particular gene sequences. It is contemplated that any probe used in the present invention will be labeled with any “reporter molecule,” so that is detectable in any detection system, including, but not limited to enzyme (e.g. ELISA, as well as enzyme-based histochemical assays), fluorescent, radioactive, and luminescent systems. It is not intended that the present invention be limited to any particular detection system or label.
[0101] A “transgene” is meant to refer to such heterologous nucleic acid, e.g., heterologous nucleic acid in the form of, e.g., an expression construct (e.g., for the production of a “knock-in” transgenic animal) or a heterologous nucleic acid that upon insertion within or adjacent a target gene results in a decrease in target gene expression (e.g., for production of a “knock-out” transgenic animal). A “knock-out” of a gene refers to the alteration in tire sequence of the gene that results in a decrease of function of the target gene, preferably such that target gene expression is undetectable or insignificant. Transgenic knock-out animals include a heterozygous knock-out of a target gene, or a homozygous knock-out of a target gene.
[0102] A “transgenic” refers to any animal or plant, in which one or more of tire cells of the animal or plant contain heterologous nucleic acid introduced by way of human intervention, such as by transgenic techniques well known in the art. The nucleic acid is introduced into the cell, directly or indirectly by introduction into a precursor of the cell, by way of deliberate genetic manipulation, such as by microinjection or by infection withBSU:2000WGa recombinant virus. The term genetic manipulation does not include classical cross-breeding, or in vitro fertilization, but rather is directed to the introduction of a recombinant DNA molecule. This molecule may be integrated within a chromosome, or it may be extrachromosomally replicating DNA. In the typical transgenic animals described herein, the transgene causes cells to express a recombinant form of one of the INP polypeptides, e.g. either agonistic or antagonistic forms. However, transgenic animals in which the recombinant INP gene is silent are also contemplated, as for example, the FLP or CRE recombinase dependent constructs described below. Moreover, “transgenic plant’’ also includes those recombinant plants in which gene disruption of one or more INP genes is caused by human intervention, including both recombination and antisense techniques.
[0103] Unlike bacterial INPs, the genetic and molecular basis of ice fonnation in other organisms is largely unknown. However, several widely distributed fungi and lichen species exhibit highly efficient and exceptionally stable ice-nucleating activity5,0,9,20that enables freezing above -5 °C. These INs function independent of cell membranes20, withstand extreme pH conditions (2-12)21, and have been confirmed as proteinaceous through circular dichroism and their sensitivity to proteolytic digestion and heat denaturation*?, 22. Size characterization experiments show fungal INPs are smaller than bacterial INPs and nucleate ice through a fundamentally distinct, non-membrane-bound mechanism5,9,22. Here, tire inventors examine the genetic basis, composition, and structure of these potent biological INs to elucidate the molecular determinants of their size, stability, and supramolecular aggregation mechanisms that drive their remarkable ice-nucleating activity.
[0104] Table 1. Examples of sequences and organisms with CRDs for use herein, sequences incorporated herein by reference.
[0105] Genome sequencing reveals orthologues of bacterial InaZ in fungi.
[0106] The inventors sequenced the genomes of the ice-nucleation-active (INA) strain 13A of Mortierella alpina20and a pure fungal culture, L01 -tf-B03. obtained from tire lichen Peltigera britannica23. DNA extracted from these INA-confirmed strains was sequenced using Illumina technology, with sequencing reads assembled into high-quality draft genomes. The genome sequences were annotated, with gene predictions informed by genomes of related species. For the M. alpina genome, the most closely related, publicly available genomes were those of other M. alpina strains, as determined by sequence similarity in the internal transcribed spacer (ITS) locus. Unexpectedly, the fungal culture derived from P. britannica also exhibited tire highest sequence similarity to species within the family Mortierellaceae . A core-genome tree using genes that were present in single copy (n=224) in all members of tire family was constructed and confirmed the identity of the M. alpina strains, but the taxonomic placement of the fungal culture from P. britannica was less clear. L01-tf-B03 clustered with two Entomortierella parvispora genomes, forming a distinct clade separate from otherEntomortierella species and sharing a common ancestor with the genus Gryganskiella. Thus, L01-tf-B03 is affiliated with E. parvispora.
[0107] SEQ ID NO: 1, Mortirella alpina (MoINP) Amino Acid Sequence
[0108] MRLFLSTLLAAALLGTMAAADVRQRQQADLRLERDHTDRLEFANYEHHDLDNSHHLEGSR DKQRRDQETPSMAPDVAVVDGAAPDVTPAPVTSGANAEVDTSASRVSSRLKHSRNKNLSHHDKND ASRLLRHNKRALELQRKKANHRKRSLWHDKKAAVPPQSDQAPSNKNGDSSHDQSTPSHEEHPGSL TSAPAVMDGTFTAQDSQPCNDTGGDNCIQFGGYNSVLTAGYNSSQTALGNSTLTARWGSNQTAGQ ESWLMAGYRSEQTAGTESSLTAGYGSTQAAGEQSVLFTGYGSTSTAGNESSIIAGYGSTQTAGVESN LTAGYGSTQTAGEHSILTAGYGSTSTAGGESVLIAGYGSTQTAGIESSLTAGYGSTQTAREHSVLTAG YGSTSTAGSESSLIAGYGSTQTAGYHSNLTAGYGSTQTAQDNSTLFSGYGSTETAGHGSSLVTGYGS TQTAGMDSTLTAGYGSTQTAREHSVLTAGYGSTSTAGSESVL1AGYGSTQTAG1ESSLTAGYGSTQT AREHSVLTAGYGSTSTAGSDSALVAGYGSTQTAGIESSLTAGYGSTQTAREHSVLTAGYGSTSTAGS ESSLIAGYGSTQTAGFCSNLTAGYGSTQTAQDESTLFAGYGSTETAGHKSSLVTGYGSTQTAGIESSL TAGYGSTQTAREHSYGSTQTAQDNSTLFAGYGSTETAGHRSSLITGYGSTQTAGIESSLTAGYGSTQ TAREHSVLTAGYGSTSTAGIESSLIAGYGSTQTAGYRSNLTAGYGSTQTAQDNSTLFAGYGSTETAG HQSSLIAGYGSTQTAGIESTLTAGYGSTQTAREHSVLTAGYGSTSTAGSESSLIAGYGSHQTAHDHSS LTAGYGSTQTAGVECNLTASYGSTQLASHNSMLVSGSQSNQTAGSHSTLIAGADSIQTAGHDSTLY AGANSILVAGDRTKLLAGSNSFITAGDFCQITCGDNCTLICGRNCTVKTGANPIVLGGCGNNE
[0109] SEQ ID NO:4, Mortirella alpina (MofNP) Nucleic Acid Sequence ATGCGTCTCTTCCTCTCAACTCTGCTGGCAGCAGCGCTGCTGGGCACCATGGCCGCCGCTGATGT CCGTCAAAGACAGCAAGCGGATTTGCGCCTTGAACGCGATCATACCGATCGTCTTGAGTTCGCC AATTACGAGCATCACGACCTCGACAACAGTCATCACCTCGAGGGTTCTCGTGACAAGCAACGTC GCGACCAGGAGACGCCATCGATGGCACCAGATGTTGCTGTTGTGGACGGCGCTGCACCTGATGT CACTCCAGCTCCAGTCACCAGCGGGGCTAATGCCGAAGTAGACACGTCGGCTTCGAGAGTAAG CTCTCGACTGAAGCACTCCAGGAACAAAAATCTTAGCCATCATGACAAGAATGACGCATCAAG ACTCCTCAGGCACAACAAGCGCGCGCTTGAGCTCCAGCGCAAGAAGGCCAATCACCGCAAAAG ATCCTTGTGGCACGACAAGAAGGCCGCCGTTCCCCCTCAAAGTGACCAGGCTCCCTCCAACAAG AATGGCGATAGTTCCCATGACCAGTCGACACCCTCGCATGAGGAGCATCCGGGTAGCCTCACTA GTGCCCCCGCAGTCATGGATGGCACGTTCACAGCTCAGGATAGCCAGCCCTGTAACGACACTGG TGGCGACAACTGCATCCAATTTGGGGGCTACAATAGCGTCCTGACTGCAGGCTACAACAGCTCT CAAACCGCCCTGGGCAACAGCACTCTTACCGCAAGGTGGGGTAGCAATCAAACAGCCGGACAA GAAAGTTGGTTAATGGCCGGCTATCGCAGTGAGCAGACGGCAGGAACAGAAAGTAGTCTGACT GCTGGTTATGGCAGCACTCAGGCTGCAGGGGAACAGAGTGTTCTTTTCACCGGCTATGGAAGTA CCTCAACTGCTGGAAACGAAAGTTCAATAATTGCTGGTTACGGCAGCACCCAGACGGCGGGAGTAGAGAGCAACCTGACTGCTGGTTATGGCAGCACGCAAACTGCAGGGGAACACAGCATCCTTA CTGCTGGCTATGGTAGCACCTCCACTGCTGGGGGCGAGAGTGTACTGATTGCTGGCTACGGTAG CACCCAGACGGCGGGAATAGAGAGCAGCCTCACTGCTGGTTATGGCAGCACACAGACTGCAAG AGAACACAGTGTCCTTACCGCCGGCTATGGCAGTACCTCCACTGCGGGCAGCGAAAGTTCACTG ATCGCTGGCTACGGCAGCACCCAAACAGCAGGCTACCATAGCAACCTGACCGCAGGCTATGGC AGCACCCAAACGGCCCAAGACAACAGCACTCTCTTCTCCGGCTACGGAAGCACTGAAACTGCT GGACATGGAAGTTCTTTGGTCACCGGGTATGGCAGCACCCAGACAGCGGGAATGGATAGCACC CTGACTGCTGGTTATGGCAGCACGCAGACTGCAAGGGAACATAGTGTCCTCACCGCCGGCTATG GTAGCACCTCCACTGCTGGGAGCGAGAGTGTACTGATTGCTGGTTACGGTAGCACTCAGACGGC GGGGATAGAGAGTAGTCTCACTGCTGGTTATGGCAGCACACAGACTGCAAGAGAACACAGTGT CCTTACCGCCGGCTATGGTAGCACCTCCACTGCTGGGAGCGACAGTGCACTGGTTGCTGGCTAC GGTAGCACCCAGACGGCGGGAATAGAGAGCAGCCTCACTGCTGGTTATGGCAGCACACAGACT GCACGAGAACACAGTGTCCTTACCGCCGGCTATGGCAGTACCTCAACTGCGGGCAGCGAAAGT TCACTGATCGCTGGCTACGGCAGCACTCAAACAGCAGGCTTCTGTAGCAACTTAACTGCAGGTT ATGGCAGCACCCAAACGGCCCAAGACGAGAGCACACTCTTCGCCGGCTATGGAAGCACGGAAA CCGCCGGCCACAAGAGCTCTTTGGTTACCGGGTATGGCAGCACTCAGACGGCAGGAATTGAAA GCAGTCTCACTGCTGGTTATGGCAGCACGCAAACTGCACGAGAACACAGCTATGGCAGCACTC AAACCGCTCAAGATAACAGCACCCTCTTCGCTGGCTACGGAAGCACTGAAACCGCAGGCCATC GAAGTTCGTTGATCACCGGGTACGGCAGCACCCAGACGGCGGGAATAGAGAGCAGTCTTACAG CTGGTTATGGCAGCACGCAAACTGCAAGAGAGCACAGTGTCCTTACCGCCGGCTATGGCAGTAC CTCAACTGCGGGAATCGAGAGTTCACTGATCGCTGGCTACGGCAGCACTCAAACAGCAGGCTA CCGCAGTAATCTGACCGCAGGCTATGGCAGCACTCAAACCGCTCAAGATAACAGCACCCTCTTC GCTGGTTACGGAAGCACTGAGACCGCAGGACACCAAAGTTCGTTGATCGCTGGCTATGGTAGC ACTCAGACGGCGGGAATAGAGAGCACTTTGACTGCTGGTTACGGAAGTACGCAGACTGCAAGA GAGCACAGTGTTCTTACCGCCGGCTATGGCAGCACCTCCACTGCGGGAAGCGAAAGTTCATTAA TCGCTGGATACGGCAGTCACCAAACCGCCCACGACCACAGCTCTCTCACCGCCGGCTACGGTAG CACACAGACGGCGGGAGTGGAATGCAACCTGACGGCTAGTTACGGCAGCACCCAACTTGCCAG TCACAATAGTATGTTGGTTAGTGGCAGTCAAAGCAACCAAACCGCAGGCAGCCACAGCACTCTC ATTGCAGGCGCCGACAGTATCCAAACTGCAGGTCATGACAGTACATTGTATGCAGGAGCAAAT AGTATACTTGTGGCTGGCGACCGAACCAAGCTCCTGGCGGGCAGCAACAGCTTCATCACGGCG GGCGATTTCTGCCAGATTACATGCGGCGATAACTGCACCTTGATCTGTGGTCGTAACTGCACCG TCAAAACAGGTGCAAACCCCATAGTGCTGGGCGGGTGTGGTAATAATGAATAA
[0110] SEQ ID NO: 2, Entomortierella parvispora (EnINP) Amino Acid Sequence
[0111] MGTADVVQEQEAGLYPERHRTQLMVPDIPGVVAVAVD VTPDPAASETTADVQTSASNMRP RREHFDKKYDNHLRKRDGSGYLKHSKRALGHYSKKASHDKAKSNGQTQLTSPDKKTDVFPQTEQASTKAGTPYAQLTYSHEQKQEDFDGTLTAQDSEVCDAIGGNNCIQLGGDDSVFVAGYNSSQTARNNS TLTAGFKSNQTAVDESRLTTGYASVQTAGERSVLTAGYGSTSTAGVESSLIAGFGSTQTAGFRSNLT AGYGSTQTTQDNSNLFAGYGSSSIAGHQSSLMAGYGSTQTAGLESSLTAGYGSTQSARERSVLTAG YGSTSTAGAESSLIAGYGSTQTAGFSSNLTAGYGSTQTAQDNSNFFAGYGSTSTAGHHSSLVAGYGS TQTAGIGSNLTSGYGSTQTAQDNSNFFTGYGSTSTAGHQSSLMAGYGSTQTAGLESSLTAGYGFRSN LTAGYGSTQTAQDNSTLFAGYGSTSTAGHQSSLVAGYGSTQTAGLESSLTAGYGSTQSAREHSVLT AGYGSTSTAGIESSLIAGYGSTQTAGFRSNLTTGYGSTQTAQDNSNLFAGYGSTETAGHQSSLIAGY GSTQTAGIESSLTAGYGSTQTARERSVLTAGYGSTSTAGTASSLIAGYGSTQTAQDGSSLSAGYGSIQ TAGMDSNLTASYNSTQIAGHKSFLISGAFSNQTAGSNTTLIAGLGSSQTAGDNSKLTAGAGSTQIAG DNSKLTAGANSILTAGDDSRLTAGANSTLLAGDRTKLLAGSNSYLLAGDFCQLTCGDNCTFICGRN CTVSAGENPNIVGQCGQ
[0112] SEQ ID NO: 5, Entomortierella parvispora (EnINP) Nucleic Acid Sequence
[0113] ATGGGC ACCGCTGATGTTGTTCAAGAACAGGAGGCCGGTCTCTACCCTGAGCGCCATCG TACGCAGTTGATGGTGCCAGATATTCCCGGTGTGGTCGCGGTTGCAGTTGATGTCACTCCTGATC CAGCCGCAAGTGAGACGACTGCGGATGTACAAACATCGGCCTCAAACATGAGACCCCGCCGCG AGCACTTTGACAAGAAGTACGACAATCATCTTCGCAAAAGAGATGGTTCAGGATACTTAAAGC ACAGCAAGCGTGCGCTCGGGCACTACAGTAAGAAAGCCAGCCACGACAAGGCCAAATCGAACG GCCAAACCCAACTGACCTCCCCGGACAAGAAGACCGACGTCTTTCCCCAAACCGAACAAGCCT CCACGAAAGCTGGCACTCCCTACGCTCAGTTGACTTACTCACACGAACAGAAGCAAGAAGACTT TGACGGCACGCTGACAGCCCAGGATAGTGAGGTCTGTGACGCGATCGGTGGCAATAACTGCAT CCAACTTGGGGGCGATGATAGCGTTTTCGTCGCAGGGTATAACAGCTCTCAAACCGCCCGGAAC AACAGCACTCTTACAGCGGGCTTTAAAAGCAACCAAACCGCTGTGGATGAAAGCAGACTGACT ACAGGCTATGCAAGTGTGCAGACTGCAGGGGAACGTAGTGTCCTCACCGCCGGCTACGGCAGC ACATCAACCGCGGGAGTCGAGAGCTCATTGATTGCTGGTTTTGGTAGCACTCAAACAGCAGGAT TTCGCAGTAACCTGACCGCCGGCTACGGAAGCACTCAAACAACTCAAGATAACAGCAATCTCTT CGCCGGCTATGGCAGCTCTTCAATCGCAGGACACCAGAGTTCGTTGATGGCAGGCTATGGCAGT ACTCAGACAGCTGGACTCGAAAGCAGCCTGACAGCCGGTTATGGTAGCACGCAGTCCGCAAGG GAACGTAGTGTCCTCACCGCCGGCTACGGCAGCACATCAACCGCGGGGGCCGAAAGCTCGTTG ATCGCTGGTTATGGTAGCACTCAAACAGCAGGATTTAGTAGTAACCTGACCGCCGGCTATGGAA GCACTCAAACAGCTCAAGATAACAGCAATTTCTTCGCCGGCTATGGCAGCACTTCCACCGCAGG ACACCACAGTTCGTTGGTGGCCGGCTATGGCAGCACTCAAACAGCAGGAATCGGTAGTAACCT GACCTCCGGCTATGGAAGCACTCAAACAGCTCAAGATAACAGCAATTTCTTCACCGGCTATGGC AGCACTTCAACCGCAGGACACCAGAGTTCGTTGATGGCAGGCTATGGCAGTACTCAGACAGCT GGACTCGAAAGCAGCCTGACAGCCGGTTATGGATTCCGTAGTAACCTGACCGCCGGCTATGGA AGCACTCAAACAGCTCAGGATAACAGTACTCTCTTCGCCGGCTATGGCAGTACGTCAACTGCAGGACACCAGAGTTCGTTGGTGGCCGGCTATGGCAGCACCCAGACAGCTGGTCTTGAGAGCAGCCT GACAGCCGGCTATGGCAGCACACAGTCCGCAAGAGAACATAGTGTTCTCACCGCCGGCTACGG CAGCACATCAACCGCGGGAATTGAGAGCTCGTTGATCGCCGGTTATGGCAGCACTCAAACAGC AGGATTCCGTAGTAACCTGACCACCGGCTATGGAAGCACTCAAACAGCTCAGGATAACAGCAA CCTCTTCGCCGGCTATGGCAGCACGGAAACTGCAGGGCACCAGAGTTCGTTGATCGCCGGCTAT GGCAGCACTCAGACAGCTGGAATCGAGAGTAGCTTAACAGCCGGTTATGGTAGCACGCAAACC GCCAGGGAACGTAGTGTCCTCACTGCCGGCTATGGCAGCACATCAACCGCGGGGACCGCGAGT TCGTTGATCGCTGGTTACGGCAGCACCCAAACCGCTCAGGATGGTAGCTCTCTCAGTGCCGGTT ATGGCAGCATCCAGACGGCGGGGATGGATAGCAACCTGACTGCTAGTTACAACAGCACCCAAA TTGCCGGCCATAAAAGCTTCCTGATCAGTGGAGCGTTCAGCAACCAAACCGCGGGCAGTAACA CTACGCTCATAGCCGGCTTGGGCAGTTCGCAAACCGCGGGCGACAACAGCAAACTAACTGCCG GTGCAGGCAGTACGCAAATCGCGGGCGACAACAGCAAACTGACTGCCGGTGCCAACAGTATAC TCACGGCTGGCGATGACAGTAGACTCACTGCTGGGGCAAATAGCACGCTCTTGGCTGGTGATCG CACCAAACTCCTGGCGGGCAGCAACAGCTATCTGTTGGCGGGCGACTTCTGCCAGCTGACGTGC GGCGATAACTGCACCTTCATATGTGGCCGTAACTGCACCGTGTCTGCAGGTGAAAACCCCAACA TAGTGGGCCAGTGTGGACAATAA
[0114] SEQ ID NO:3, Podila clonocytis (PoINP) Amino Acid Sequence
[0115] MRAFLSILLA TALLGIMTTA DVVQEQEAAF RPEPHHTPSI ASDIPVVVVA AVDVAPDPAA SEAIVEVDTS TSNMRHRREH FDKKNYKHNR KRAVSRHLKH SKRALGLHSK NVNHDKKATS NDQTEQASLD KKADVFPQTE QASPNKKADT SNAQSTHSRE EQQGDFDGTL TAQDSQLCPA IGGNNCIQFG EDDSIFVAGY NSTQTARENS TLTAGYNSTQ TAVDTSKLTA GYASVQTAGE HSVLTAGYGS TSTAGIESSL IAGYGSTQTA GFRSNLTAGY GSTQTAQDNS TLFAGYGSTE TAGHQSSLIA GYGSTQTAGI ESSLTAGYGS TQSAREHSVL TAGYGSTSTA GIESSLIAGY GSTQTAGFRS NLTAGYGSTQ TAQDNSNLFA GYGSTETAGH QSSLIAGYGS TQTAGIESSL TAGYGSTQTA REHSVLTAGY GSTSTAG1AS SL1AGYGSTQ TAQDRSSLTA GYGSTQTAGM ESNLTASYNS TQLAGHKSFL VSGAHSNQTA GSYATLVAGL GSTQTAGDNS KLTAGAGSTQ TAGDNSKLTA GANSMLTAGD DSKLTAGANS TLMAGDRTKL LAGSNSYLLA GDFCQLTCGD NCTFICGRNC TVSAGANPHM VGECGK
[0116] SEQ ID NO: 6, Podila clonocytis (PoINP) Nucleic Acid Sequence ATGCGTGCCTTCCTCTCGATTCTGTTGGCAACTGCCCTGTTGGGCATCATGACCACCGCTGATGT TGTTCAAGAACAGGAGGCCGCCTTCCGCCCTGAACCCCATCATACGCCGTCGATAGCGTCAGAT ATTCCTGTTGTGGTCGTGGCTGCAGTTGATGTCGCTCCTGATCCAGCCGCCAGCGAGGCGATTGT GGAAGTAGACACATCGACCTCAAACATGAGACATCGCCGCGAGCACTTTGACAAGAAGAACTA CAAACATAATCGCAAGAGAGCGGTTTCACGACACCTCAAGCACAGCAAGCGTGCGCTCGGGCTBSU:2000WG CCACAGCAAGAACGTCAACCACGACAAGAAGGCCACATCGAACGACCAAACCGAACAGGCCTC CTTAGACAAGAAGGCTGACGTCTTTCCCCAAACCGAACAAGCCTCCCCAAACAAGAAGGCTGA CACTTCCAATGCCCAGTCGACTCACTCACGTGAGGAGCAGCAGGGAGACTTTGACGGCACGCTG ACAGCCCAGGATAGTCAACTCTGTCCTGCGATCGGTGGCAATAACTGCATCCAATTTGGGGAGG ACGATAGCATTTTCGTTGCAGGATATAACAGCACTCAAACCGCCCGGGAAAACAGCACTCTTAC AGCAGGCTATAACAGCACCCAAACCGCCGTGGACACAAGCAAACTTACCGCAGGTTATGCAAG CGTGCAGACTGCAGGGGAACATAGTGTCCTCACCGCCGGCTATGGCAGCACTTCAACTGCGGG GATCGAGAGTTCGTTGATCGCTGGCTATGGAAGCACTCAAACAGCAGGCTTCCGTAGTAACCTG ACCGCTGGCTATGGAAGCACTCAAACAGCTCAGGATAACAGCACTCTCTTTGCTGGCTATGGCA GCACTGAGACTGCAGGACACCAGAGTTCGTTGATCGCCGGCTATGGCAGCACCCAGACAGCTG GAATCGAGAGCAGCCTGACAGCCGGCTATGGCAGCACGCAGTCTGCAAGGGAACATAGTGTCC TCACCGCCGGCTATGGCAGCACTTCAACTGCGGGGATCGAGAGTTCGTTGATCGCTGGCTATGG TAGCACTCAAACAGCAGGCTTCCGTAGTAACCTGACCGCTGGCTATGGAAGCACTCAAACAGCT CAGGATAACAGCAATCTCTTCGCTGGCTATGGTAGCACTGAAACCGCAGGACACCAGAGTTCGT TGATCGCCGGCTATGGCAGCACCCAGACAGCTGGAATCGAGAGCAGCCTGACAGCCGGCTATG GCAGCACGCAGACCGCAAGGGAACATAGTGTCCTCACCGCCGGCTATGGCAGCACTTCGACCG CGGGGATCGCGAGTTCGTTGATCGCTGGCTATGGCAGCACCCAAACCGCTCAAGATCGCAGCTC TCTCACCGCTGGCTATGGCAGCACCCAGACGGCAGGAATGGAAAGCAACCTGACTGCTAGTTA CAACAGCACTCAACTTGCTGGCCATAAAAGCTTCCTGGTCAGTGGCGCGCATAGCAACCAAACC GCAGGTAGTTACGCTACGCTCGTTGCCGGCTTGGGCAGTACGCAAACCGCGGGCGACAACAGC AAACTGACTGCCGGTGCGGGCAGTACGCAAACCGCAGGCGACAACAGCAAACTGACTGCCGGT GCCAACAGTATGCTAACGGCTGGCGATGACAGTAAACTGACTGCCGGGGCAAACAGCACGCTC ATGGCTGGCGATCGAACCAAACTCCTGGCGGGCAGCAACAGCTATCTCTTGGCGGGTGACTTCT GCCAGCTGACGTGCGGCGATAACTGCACCTTCATATGCGGACGTAACTGCACCGTGTCTGCAGG TGCAAACCCTCACATGGTGGGCGAGTGTGGAAAATAA
[0117] Next, the inventors screened the sequences for INPs by searching for conserved regions and known ice-binding motifs, such as TxT and SLT. Using this approach, the inventors identified two candidate INP sequences, which were analyzed for similarity to bacterial INPs. A basic local alignment search was performed to identify regions of sequence similarity on the protein level between the fungal INPs, known bacterial INPs. and other potential INPs. Using this approach, the inventors identified a third potential INP with high sequence similarity from Podila clonocytis, also in the Mortierellaceae family24. FIG. 1 A presents the comparative analysis of fungal and bacterial INP sequences. It was found that the INPs from M. alpina (A-folNP), E. parvispora (A / / I N P). and P. clonocytis (Pol N P ) consist of 990 ( 100 kDa), 809 (81.8 kDa), and 606 (64 kDa) amino acids, respectively. These fungal INPs are smaller than the 120 kDa INPs from P. syringae (U.sINP)but significantly larger than the <50 kDa sizes estimated from molecular weight cutoff filtration experiments (FIG. 3).
[0118] Multiple sequence alignments reveal that fungal INPs share high sequence similarity' with each other (-75%) and with bacterial InaZ proteins (-58%) despite the differences in size (FIG. 6). For P. syringae, the P INP gene encodes a long |3-solenoid fold, comprising a CRD with 51 coils and 10 charge-rich coils, each consisting of 16 residues (FIG. 1A). C.sINP further features a short C-tenninal region and a long, flexible N-tenninal domain. The length, location, and sequence of charged and the CRD-to-charged-coil ratio are highly conserved across bacterial INPs and likely critical for INP multimerization25. The largest sequence overlap between fungal and bacterial INPs occurs in the CRD, with nearly 100% similarity. This region contains repetitive TxT and SxLT motifs (FIG. IB), which serve as putative ice-nucleating motifs 15, 19. The other highly conserved Tyrosine-Glycine-Serine (YGS) motifs are likely not involved in water ordering but rather provide an INP dimerization interface 16,26,27. The fungal INPs also possess flexible N-terminal domains of varying lengths but lack a defined membrane -anchoring region. Tire charge-rich coils near the C -terminus exhibit fewer repetitive motifs, and the alignment of annotated INP gene regions reveals lower sequence conservation between fungi and bacteria (FIGS. 1A-1D, FIG. 6). Interestingly, all fungal INPs contain six cysteine residues near the C-terminus and two cysteine residues at the start of the CRD domain, which are capable of disulfide bond formation. These features are unique to fungal INPs, likely playing key roles in their structural arrangement and stability.
[0119] Given tire protein similarities, the inventors performed a phylogenetic analysis to compare the DNA sequences of bacterial InaZ genes and the genes encoding the fungal INP to determine whether these similarities arose through convergent evolution or horizontal gene transfer (HGT). A phylogenetic tree of 218 InaZ orthologues was found in the bacterial genera Pantoea, Pseudomonas, and Xanthomonas and 16 InaZ orthologues identified in the Mortierellaceae (encoding the three proteins described above and 13 orthologues found in additional Mortierellaceae genome sequences. The 16 INP genes from the Mortierellaceae family form a single cluster that shares a most recent common ancestor (MRCA) with InaZ orthologues of Pseudomonas mandelii. However, the bootstrap support for tire MRCA is only 61%, while the first node with a high support is the node representing the MRCA of the Mortierellaceae, P. mandelii, P.fluorescens, and Pantoea InaZ sequences. This suggests that the InaZ gene was originally acquired by an ancient Mortierellaceae strain through an HGT event from an ancient bacterial strain that had an InaZ gene sequence ancestral to today’s P. mandelii, P. fluorescens, and Pantoea strains. The fungal INPs further exhibit unique features that are entirely absent in bacterial INPs. These findings show that while the core INP framework was likely acquired from bacteria via HGT, subsequent evolutionary adaptations, such as a merger with a fungal gene, optimized their function in fungi.
[0120] Genetic confirmation of fungal InciZ orthologues as encoding INP.
[0121] To confinn that the proteins encoded by the fungal orthologues of the bacterial InaZ gene do, in fact, carry INA, the InaZ orthologues of AT. alpina 13 A, which encodes AfoINP. and of' E. parvispora, LOl-tf-B03, which encodes / T / INP. were amplified using polymerase chain reaction and inserted into a yeast expression vector. After sequence confirmation, the constructs were moved into yeast (Saccharomyces cerevisiae) cells, which were subsequently cultured on plates with galactose as the carbon source to induce the production of Mo IN P or A / iINP. The inventors evaluated the INA of the yeast suspensions and tested each condition in a droplet freezing assay spanning -6°C to -12°C. No freezing events were observed in the negative control (water) or the control strain (5. cerevisiae). In contrast, yeast cells with the genes encoding ol NP or A7 / INP consistently induced ice nucleation above -12°C (FIG. 7). These results genetically demonstrate that the InaZ orthologues of Mortierellaceae are able to induce INA in yeast, and that AfolNP and / zINP are the INPs responsible for INA in Mortierellaceae .
[0122] Structure of AfolNP, A / / INP. and EoINP predicted by AlphaFold3.
[0123] FIGS. 2A to 2C show the AlphaFold3 model of / j / INP from / .’, parvispora 28. The structure consists of an N-tenninal domain with a 158-residue flexible linker, followed by a central repetitive domain of approximately 19 nm, modeled as a continuous |3-solenoid. Within the [3-solenoid fold, each 16-residue repeat fonns a single coil, and the overall fold closely resembles the previously characterized bacterial INP [3-solenoids. Tire [3-solenoid can be divided into two distinct regions. The first region consists of 20 coils with a highly repetitive sequence, containing conserved TxT. SLT, and YGS motifs. These motifs form long parallel arrays that are likely responsible for the ice-nucleating function of the fungal protein 15, 19, and the cross-sectional geometry of the motifs is identical to that found in bacterial INPs. The second region forms a transition zone, where the repetitive sequence becomes less conserved. This region consists of seven coils, includes the C-tenninal domain, and lacks repetitive sequence features. Instead, it contains positively and negatively charged amino acids distributed in patches (FIGS. 8, 9) likely assisting in the intennolecular assembly of the INPs. Moreover, the region contains six cysteine residues that are capable of forming disulfide bonds. An additional pair of cysteines is located near the beginning of the [3-solenoid fold. Disulfide bonds are known to stabilize antifreeze protein solenoids29, but in Ei / INPs. they function as structural caps of the [3-solenoid, preserving tire fold and preventing end-to-end associations. This stabilization mechanism clearly differentiates fungal INPs from bacterial INPs, where the C-terminal region is enriched in arginine residues and contains a 41 -residue C-terminal cap structure, while the N-terminal cap is unknown. Over the 28 repeats, the En N P model predicts a slight left-handed twist in the solenoid, similar to bacterial INPs . The slight rotation between adjacent coils will likely be eliminated as neighboring solenoids dimerize, forming a large flat surface required for efficient ice nucleation 19.BSU:2000WG
[0124] In / 'MNP. positively charged lysine and arginine residues are clustering near the C -terminus, while negatively charged aspartic and glutamic acid residues are localized near the N-tenninus, all positioned on one side of the solenoid. In contrast A / rINPs show a more evenly distributed charge pattern with alternating positive and negative residues rather than distinct clusters. Additionally, fungal INPs feature a highly charged N-terminal flexible linker, characterized by distinct patches of positive and negative charge, further distinguishing them from bacterial INPs. Interestingly, the fungal INPs also incorporate histidine residues, which are largely absent in bacterial INPs. By way of explanation, but it no way a limitation of the present invention, it is hypothesized that this adaptation reflects the lower overall pH in fungi, where histidine remains positively charged. Overall, the differences in electrostatic surface properties are likely to influence INP multimerization and stabilization.
[0125] Next, the inventors modeled the protein structures of putative INPs from additional INA fungal strains (FIG. 10). The AfolNP and oINP exhibit structural characteristics similar to the / fir IN P. differing primarily in the length of the solenoids and composition of the N-terminal flexible linker. The lengths of the solenoids of AfolNP, / T / INP. and PoINP are 25.3 nm, 19 nm, and 13.5 nm, respectively. All the fungal INPs share a molecular width of only 3.4 nm, which can explain the smaller and apparently inconsistent values obtained in fdtration experiments (<50 kDa MWCO, FIG. 3). The elongated solenoids can pass through fdters with pore sizes in the 3-5 nm range, highlighting the limited applicability of fdtration results for characterizing the size of INPs9.
[0126] Multimerization enables high fungal ice nucleation activity
[0127] FIG. 4A shows the results of icc nucleation experiments with aqueous extracts from the mycelia and spores of ice-nucleation active strains M. alpina and E. parvispora. The cumulative freezing spectra comprise a complete dilution series with initial extract concentrations of ~ 1 mg mL'1. They exhibit two distinct increases in the cumulative number of ice nuclei per unit mass, Nm(I), for / / . parvispora at — 5.6 °C and ~ -6.5 °C, while M. alpina exhibits a single rise at — 4.8 °C, followed by a plateau below -8 °C, confirming that the investigated fungal INs are indeed highly efficient20,30. The corresponding differential freezing spectra in FIG. 4B show the icc nucleation temperature distributions for M. alpina and E. parvispora derived from the experimental Nm(T) dataset using the heterogeneous underlying -based (HUB) backward code31. which fits the experimental Nm(T) data of droplet freezing experiments by a linear combination of Gaussian subpopulations. Tire best-fit differential spectra exhibit two Gaussian subpopulations centered at -5.9 °C and -7.5 °C for M. alpina, and three subpopulations at -5.6 °C. -6.5 °C, and -7.5 °C for E. parvispora.
[0128] The INPs provide a surface that can bind and order water molecules, thereby reducing the free energy barrier for ice nucleation. To estimate the number of INPs required to form aggregates capable of promoting ice nucleation at the observed freezing temperatures, the inventors applied the Heterogeneous Ice NucleationTemperature (HINT) algorithm19, which employs a numerical implementation of Classical Nucleation Theory (CNT) to determine the free energy barriers associated with ice fomiation and growth on finite surfaces. Leveraging experimentally derived thermodynamic properties of water, HINT enables calculations of the heterogeneous freezing temperature as a function of surface size. Hie simulations showed that increasing the length of the water-organizing [3-helix in INPs has minimal impact on the ice nucleation temperature, whereas expanding the width by parallel aligning INPs enhances nucleation efficiency 19. In these calculations, the inventors assumed that the ice-binding surface is flat, that the distance between monomers remains constant, and that the monomer size is characterized by the AlphaFold3 parameters of the solenoid (length: 25.3 nm AfolNP, 19 nm / ft / INP: width 3.4 nm). FIG. 4C shows the ice nucleation temperatures predicted for side-by-side INP aggregates of AToINP and A / / INP. This comparison indicates that, for E. parvispora and M. alpina, the freezing modes that exhibit lower nucleation efficiency (-7.5 °C) originate from INP trimers, whereas the more efficient ice-nucleating structure (-6.5 °C and -5.9 °C, respectively) correspond to INP tetramers. The highest freezing mode of E. parvispora at -5.6 °C can be attributed to the formation of INP pentamers.
[0129] This finding raises tire question of what governs the aggregation and ice-nucleating activity of fungal INP multimers. FIGS. 5Ato 5C shows a mechanism ofINPmultimerization into functional units. Tire inventors interpret fungal INP dimerization as driven by the stacking of highly conserved tyrosine (Tyr) ladders, a rapid process also suggested for bacterial INPs 16,26,27. The Tyr-ladders create a structurally aligned surface, orienting ice-nucleating motifs in parallel and expanding the effective nucleation site. Further aggregation and multimer formation is likely mediated by electrostatics 16. The electrostatic surface models (FIGS. 5 A. 8, 9) of the fungal INPs reveal distinct charge distributions along the solenoid and the flexible N-terminal linker, thus, multimerization arises from attraction between oppositely charged residues and is stabilized by the N-terminal linker, enhancing structural integrity and assembly efficiency. Importantly, the freezing spectra of the INP multimers remain extremely stable, showing negligible changes after freeze-thaw cycles, pH treatment, surfactant, or membrane fluidizer exposure. Combined with the evidence that ice nucleation activity in M. alpina resists lipases and remains active in cell-free systems20, these results show that fungal INP multimerization and freezing efficiency are membrane-independent9,20,32.
[0130] The discovery' of a new class of fungal INPs shows how organisms overcome the kinetic barriers of ice formation. Despite their distant taxonomic origins, fungal and bacterial INPs share a conserved 0-solenoid architecture and multimerization strategy, hallmarks of highly efficient ice nucleation9. However, fungal INPs function without membrane attachment and achieve stability through a distinct disulfide capping mechanism 15.29, highlighting how similar structural outcomes can emerge through divergent evolutionary paths. These findings show that HGT enabled fungi to co-opt a bacterial ice-nucleation framework, which was subsequently adapted for soluble, cell-free activity. This convergence underscores fundamental physical constraints on protein-mediated ice nucleation, while revealing the versatility' of biological solutions toBSU:2000WGenvironmental challenges. Beyond their biological significance, the fungal INPs exhibit extraordinary stability and potency, functioning at picomolar concentrations and under extreme conditions. Their membrane -independence and solubility unlock new possibilities for bioinspired freezing technologies, from precision cryopreservation to engineered weather modulation. The identification of such proteins in common soil fungi further raises the possibility that their contribution to atmospheric ice nucleation is currently underestimated20,33. Future work should focus on quantifying their environmental prevalence and exploring their potential in synthetic and applied contexts. More broadly, this study shows how gene transfer and structural convergence can drive evolutionary innovation at the interface of biology and phy sics.
[0131] Genome sequencing.
[0132] Strains were grown on potato dextrose agar or malt yeast extract agar for two to four weeks at room temperature1-3, and the mycelium was harvested using an ethanol sterilized razor blade. DNA was extracted using the QIAGEN All Prep Fungal DNA / RNA / Protein Kit (Hilden, Germany). DNA was eluted in molecular grade water and stored at -80°C until sequencing.
[0133] Short read sequencing was done on an Illumina NovaSeq X sequencer by SeqCenter (Pittsburgh, PA) . Quality control and adapter trimming were done by the company. Genome assembly was done using SPAdes version 3.15.5. The assembled genomes were then annotated using Augustus version 3.5.0 using Fusarium graminearum as the model4,5.
[0134] Core genome phylogeny of the Mortierellaceae
[0135] To identify the genus and species of the isolates the ITS (Internal Transcribed Spacer) region (ITS1, 5.8 S, and ITS2) was extracted using ITSx version 1.136. The ITS region was blasted on NCBI and was found to be most closely associatedMortierellaceae sequences. Mortierellaceae genomes used in a previous study were used to identify the specific genus and species of the isolates?. Tire whole genome assemblies of fungal genomes were downloaded from the NCBI Genome Assembly database on Inly 24th, 2024, using the ncbi-datasets-cli tool version 14.2.28. To construct a core genome tree, a combination of tools were employed: Benchmarking Universal Single-Copy Orthologs (BUSCO) version 5.8.2 to identify single-copy genes. MUSCLE version 5.3 to align the identified single-copy genes9. and TrimAI version 1.5 to remove poorly aligned sequenceslO. The core phylogenetic trees were constructed using IQ-TREE version 2.3 with maximum likelihood and ultrafast bootstrapping 11. Consensus trees were visualized using ggtree on R version 4.3.3 (Angel Food Cake)12,13. Linnemannia hyalina w Mortierella hygrophila were used as outgroup.
[0136] Phylogenetic analysis of bacterial and fungal InaZ orthologues
[0137] Several gene sequences associated with ice nucleation activity were downloaded from UniProt on February 10th. im . InaZ ixom Pse domonas syringae (CAA26837.1) was used as a query sequence againstBSU:2000WGa custom database of genome assemblies of the Mor tier ellaceae and Gammaproteobacteria assemblies. To identify potential orthologues. 50% identity, 200 alignment length, and an e-value < le'5were used to filter results. Overlapping sequences found on the same contig were merged using the bedtools merge version 2.31.1 function 14. Only the best hit (highest percent identity) was retained for each assembly (Table SI) and was used for phylogenetic analysis. Potential orthologues were then aligned using MUSCLE version 5.3 and TrimAl version 1.5 was used to remove poorly aligned sequenceslO,ll. The phylogenetic tree was constructed using IQTree version 2.3 with maximum likelihood and ultrafast bootstrapping 12. The predicted root for the tree was found by calculating bootstrap values with IQTREE using non-reversible models using the -model-joint UNREST flag 15. Trees were visualized using ggtree on R version 4.3.3 (Angel Food Cake).
[0138] Cloning of fungal InaZ orthologues in Saccharomyces cerevisiae and confirmation of INA
[0139] The Mortierella alpina g9171 coding sequence was amplified with sense primer VTXW3636 (CTATACTTTAACTGCAGTTTAATTAATGCGTCTCTTCCTCTCAA) (SEQ ID NO:8) and antisense primer VTXW3637 (GCGAAGAAGTCCAAAGCTGGATCCTCATTCATTATTACCACACC) (SEQ ID NO:9). The Entomortierella parvispora g6506 coding sequence was amplified with sense primer XW3642 (CTATACTTTAACTGCAGTTTAATTAATGGGCACCGCTGATGTT) (SEQ ID NO: 10) and antisense primer VTXW4643 (GCGAAGAAGTCCAAAGCTGGATCCTTATTGTCCACACTGGCC) (SEQ ID NO: 11) using PrimeSTAR Max DNA polymerase (Takara Bio, CA). PCR reactions were preformed using an epGradient Mastercycler (Eppendorf, CT) for 30 cycles with the following settings: 94 °C for 10 seconds; 55 °C for 10 seconds; and 68 °C for 30 seconds, followed by a 5-minute extension at 68 °C. PCR products were separated using agarose gel electrophoresis and purified using the AccuPrep PCR / Gel purification kit (Bioneer, CA). The gel-purified PCR fragments were cloned into a Pacl and TzoI-digested pBlYT3-FLAG-HA plasmid using the Genbuilder kit (Genscript, NJ) to make pU33-Ma_g9171 and pU33-EP_g6506. Both FLAG and HA tags were removed during cloning and therefore, authentic proteins will be produced in yeast cells upon induction. After sequencing, plasmid DNA was transformed into yeast strain YPH500 (MAT-alpha. wra3-52 / j’. 2-801 ada2-10L trpl-63 his3-200 leu2-\) by the lithium acetate methodl6. After transformation, yeast cells were plated onto synthetic complete (SC) medium with 2% glucose as a carbon source but lacking uracil (SC-U) to maintain a selection for the plasmid. To assess INA, yeast cells harboring pU33-Mag9171 or pU33-EPg6506, or yeast cells harboring pBlYT3-FLAG-HA as tire negative control were streaked onto SC-U plates containing 2% galactose and incubated at 30 °C for 36 hours to induce gene expression. As control, the same strains were grown on SC-U plates containing 2% glucose, which represses the expression of target genes.
[0140] Fungal culture and sample preparation.
[0141] Fifty plates of the ice nucleation-active fungal species Mortierella alpina or Entomortierella parvispora were grown on full-strength potato dextrose agar plates (VWR International GmbH) and malt yeast extract agar plates (Difco™ Malt Extract Broth, Fisher Scientific, United States), respectively. Growth occurred at room temperature for two weeks and then at 4 °C for about four weeks. Pure water was obtained from Millipore Milli-Q® Integral 3 w ater purification system (Merck Chemicals GmbH), autoclaved at 121 °C for 15 min, and filtered through a 0.1 pm bottle top filtration unit (VWR International GmbH). For the droplet freezing experiments, aqueous extracts of fungal mycelium were prepared as described previously with the following modifications (10). The fungal mycelium of five agar plates was collected in a sterile 50 mL tube, and the weight of the mycelium was determined gravimetrically. Aliquots of 50 mL of pure w ater were added to the mycelium. The samples were vortexed three times at 2,700 rpm for 1 min. The aqueous extracts for all experiments were filtered through a 0.1 pm bottle-top filtration unit (VWR International GmbH), and the resulting aqueous extracts contained ice nucleators from spores and mycelial surfaces. For filtration experiments, the 0.1 pm filtrate was filtered through 50 kDa MWCO PES ultrafiltration centrifugation units (Thermo Fisher Scientific), and the ice nucleator concentration was determined by TINA measurements.
[0142] TINA experiments.
[0143] Ice nucleation experiments were performed using the high-throughput Twin-plate Ice Nucleation Assay (TINA), which has been described in detail elsewhere17. In a typical experiment, the investigated IN sample was serially diluted 10-fold by a liquid handling station (epMotion ep5073, Eppendorf). Then, 96 droplets (3 pL) per dilution were placed on two 384-w'ell plates and tested with a continuous cooling rate of 1 °C / min from 0 °C to -30 °C with a temperature uncertainty of ±0.2 °C. The droplet-freezing was determined by two infrared cameras (Seek Therman Compact XR, Seek Thermal Inc.). For each experiment, the obtained fraction of frozen droplets (fice) and the counting error were used to calculate the cumulative number of IN (Nm) with the associated error using Vali’s formula and Gaussian error propagation! 8. All experiments were performed at least three times. Background freezing of pure water in this system occurred at ~ -22 °C. Independent samples were found from individual fungal cultures show similar results with minor variations, consistent with previous studies 1,17.
[0144] Identification of the ice nucleating subpopulations through HUB analysis.
[0145] The HUB method19w as utilized for tire identification and quantification of the subpopulations that constitute the experimental cumulative freezing spectra. This method uses a stochastic optimization technique to extract the underlying distribution of heterogeneous ice nucleation temperatures Pu(T) that describes the characteristic freezing temperatures of all INs in a sample. For this, the HUB-backward code available as a Python code (gitliub.com / Molinero-Group / underlying-distribution) was used to compute the differential freezing spectra nm(T), representing Pu(T), from the cumulative freezing spectra Nm(T) obtained from TINAexperiments. Pu(T) is assumed to be a linear combination of normalized Gaussian distribution functions Pi(T) that represents a distinct number of subpopulations p of the weights ci that give= 1. Each subpopulation P / (T) is characterized by its characteristic freezing temperature mode Tmode,i and the spread of the temperature distribution si. The experimentally obtained Nm(T) is interpolated through a spline and smoothed with a Savitzky-Golay filter of first polynomial order with a default value of 3 for the length of the filter window. The mean squared error MSE defines the accuracy of the determined set of parameters for the distribution function. For analysis, optimized results with the lowest MSE were selected.
[0146] Prediction of the protein structures with AlphaFold3.
[0147] AlphaFold3 was used for structure predictions20. The best-ranked (i.e., with the overall highest pLDDT scores) AlphaFold monomer models predict INP P-helix with a slight twist. The AlphaFold predictions of INP dimers and multimeric aggregates exhibited twisted and kinked structures that do not match the observed high ice nucleation temperatures. All models were constructed using the same settings (version = 2, modelSeeds = 123).
[0148] Prediction of the ice nucleation temperatures of INP aggregates.
[0149] The HINT algorithm utilizes Classical Nucleation Theory (CNT) to predict the heterogeneous ice nucleation temperature on finite surfaces by incorporating experimentally detennined thermodynamic and kinetic properties of water, along with tire binding free energy of the ice-nucleating (IN) particle to ice ( ybind)21. It systematically varies the shape and size of the ice nucleus — defined by the number of water molecules (N*) and the contact angle (9) — on a given surface geometry, optimizing these parameters to ensure that the heterogeneous nucleation rate matches the homogeneous nucleation rate under equivalent cooling conditions. As a reference, the homogeneous ice nucleation rate is set at 102s ' at 238 K for microliter droplets cooled at 1 °C / min22. The inventors started by assuming that the fungal INP bind ice as strong as ice itself, i.e., Aybind = -2 yice-iiquid. Additionally, a line tension of r = 10 pN was considered. The IN surface of A / zINP and AfolNP area is assumed to be rectangular, with widths of W = 3.4 nm and lengths L = 19 nm and 25.3. respectively, consistent with the structure predicted by AlphaFold3. That functional aggregates with n INP have width Wn = n x 3.4 nm and length L = 19 nm (A / dNP) were assumed; 25.3 nm (AfolNP), consistent with the model of assembly disclosed herein.
[0150] Using the HINT code, the free energy cost AG was calculate for various configurations by adjusting the number of water molecules N* and the contact angle 0 of the ice nucleus on the nucleating surface (3). This allows us to identify the optimal size for ice growth with the lowest energy cost, determined by the smallest AG for a specific number of water molecules. From this set. the ice nucleation barrier AG*(T) was identified, which corresponds to the highest value of A*(T) within a temperature range from Tm to Thom, with aresolution of 0.1 K. The computation was continued until the calculated AG*(T) matches the value derived from the homogeneous nucleation rate (3).
[0151] Genetic confirmation of fungal InaZ orthologues as encoding Inpro. To confirm that the proteins encoded by the fungal orthologues of tire bacterial InaZ gene do, in fact, have ice nucleation activity, plasmids carrying the InaZ orthologues from M. alpina 13A (TfoINpro) and E. parvispora L01-tf-B03 (E lNpro) were constructed and introduced in Saccharomyces cerevisiae and Escherichia coli. No freezing events were observed in the negative controls: water or the control strains (5. cerevisiae, E. coli) not expressing InaZ orthologues. In contrast, FIGS. 12Ato 12D shows that heterologous expression of AfoINpro and A7 / INpro in S. cerevisiae is sufficient to confer potent ice nucleation activity . For AfoINpro, expression in yeast shifts the nucleation from -26 °C to Tso — 7.1 °C, while expression in A. coli shifts it to To — 14.4 °C. For A / rINpro. expression in yeast results in a shift to To — 7.4 °C, and in E. coli to To — 15.3 °C. To is defined as the temperature at which 50% of droplets in the assay have frozen. These results establish that the identified genes encode active INpros. Dilution series and cumulative freezing spectra (FIG. 12B) confirm that this gain of function is unambiguous and, in the case of E lNpro, resembles the activity of the native host within + / -TC. Tie activity’ profiles of AfolNpro and E lNpro expressed in E. coli do not reproduce the profiles observed in the native fungi. Such differences are expected when proteins are expressed outside their native host, where differences in pH and ionic conditions, membrane composition, and organism-specific cofactors can affect protein assembly. Consistent with this, previous studies have shown that heterologous expression of bacterial InaZ in yeast and plant cells reduced activity compared to native bacteria, whereas expression in closely related Gram-negative bacteria yields activities that more closely match those of the native bacteria. Yet, only deleting the InaZ orthologue in aMortierellaceae strain and observing a loss of ice nucleation activity would formally prove that the InaZ orthologues not only encode INpros but are also the sole genes required for ice nucleation activity in native Mor tier ellaceae. However, given the high sequence similarity between fungal and bacterial InaZ genes and the demonstrated sufficiency of fungal InaZ genes in conferring ice nucleation activity to bacteria and yeast, it is highly unlikely that different, or additional, genes are required for this function in Mortierellaceae .
[0152] FIGS. 13A to 13C show freezing experiments with aqueous samples of fungal Ins from M. alpina and E. parvispora. (FIG. 13A) Cumulative freezing spectra (number of INs per unit mass, Nm) measured for M. alpina and E. parvispora. The lines represent the optimized solution obtained using the HUB-backward code, assuming that the differential spectra consist of two Gaussian subpopulations for M. alpina (blue line) and three Gaussian subpopulations for E. parvispora (dark red line) as shown in the next panel. (FIG. 13B) Differential freezing spectra (normalized distribution function, nm(T)) derived from (FIG. 13 A) exhibiting modal freezing temperatures of -5.9 °C and -7.5 °C forAfoINpros and -5.6 °C, -6.5 °C, -7.5 °C for AMNpros.(FIG. 13C) Ice nucleation temperatures predicted as a function of the number of aggregated INpros from M. alpina and E. parvispora based on Classical Nucleation Theory (CNT) as implemented in the HINT algorithm. Circles and squares indicate the freezing temperatures of rectangular surfaces formed by parallel-aligned INpro monomers, assuming an ice-binding surface of 3.4 nm width and a length of 25.3 nm for AToINpro (top line) and 19 nm for A / vINpro (bottom line), based on AlphaFold3 structural predictions.
[0153] Cloning of fungal InaZ orthologues in S. cerevisiae and E. coli and confirmation of ice nucleation activity. To clone INpro genes into a yeast vector, the Mortierella alpina AfoINpro (g9171) coding sequence was amplified with sense primer VTXW3636 (CTATACTTTAACTGCAGTTTAATTAATGCGTCTCTTCCTCTCAA (SEQ ID NO: 13)), bold sequences are from M. alpina 13A. and antisense primer VTXW3637 (GCGAAGAAGTCCAAAGCTGGATCCTCATTCATTATTACCACACC (SEQ ID NO: 14)). The E. parvispora L01-tf-B03 / j / INpro (g6506) coding sequence was amplified with sense primer XW3642 (CTATACTTTAACTGCAGTTTAATTAATGGGCACCGCTGATGTT (SEQ ID NO: 15)), underlid sequences are from E. parvispora, and antisense primer VTXW4643 (GCGAAGAAGTCCAAAGCTGGATCCTTATTGTCCACACTGGCC (SEQ ID NO: 16)) by using PrimeSTAR Max DNA polymerase (Takara Bio, CA) in an epGradient Mastercycler (Eppendorf. CT) as below: 98 °C10 seconds to denature DNA templates; 30 cycles with the following settings: 98 °C for 10 seconds; 55 °C for 10 seconds; and 68 °C for 30 seconds, followed by a 5-minute extension at 68 °C. PCR products were separated using agarose gel electrophoresis and purified using the AccuPrep PCR / Gel purification kit (Bioneer, CA). The gel-purified PCR fragments were cloned into a Pad and TzoI-digested pB!YT3-FLAG-HA plasmid using the Genbuilder kit (Genscript, NJ) to make pU33-Mag9171 and pU33-EPg6506. Both FLAG and HA tags were removed during cloning, and therefore, authentic proteins will be produced in yeast cells upon induction. After sequencing, plasmid DNA was transformed into yeast strain YPH500 (MAT-alpha, ura3-52 / JA -801 «tA / 2-I I irpl-63 his3-200 leu2-l) by the lithium acetate method(56). After transformation, yeast cells were plated onto synthetic complete (SC) medium with 2% glucose as a carbon source but lacking uracil (SC-U) to maintain a selection for the plasmid. To assess ice nucleation activity, yeast cells harboring pU33-Mag9171 or pU33-EPg6506, or yeast cells harboring pRS416 as the negative control were streaked onto SC-U plates containing 2% galactose and incubated at 30 °C for >36 hours to induce gene expression. For expression in bacteria, the INpro gene sequences of E. parvispora (g6506) and AT. alpina (g9171) were synthesized and subcloned with an His-SUMO tag into the expression vector pET-16b by Genscript (Genscript, Netherlands). The resulting plasmids were transformed into ClearColi electrocompetent cells (Biosearch Technologies, Germany) by electroporation. ClearColi cells are a genetically modified E. coli strain designed to reduce endotoxin contaminations in protein preparations. pUC19 DNA(Biosearch Technologies, Germany) and endotoxin free water served as positive and negative transformation controls, respectively. After transformation, bacterial cells were plated onto LB-Miller agar with ampicillin (100 pg / mL) and grown at 37 °C for 24 hours. Single colonies visible after 24 hours were transferred to 5 mL loose-lid tubes of LB-Miller medium with ampicillin (100 pg / mL) and incubated overnight at 37 °C with 200 rpm shaking. The following day, 250 mL of prewarmed LB-Miller medium with ampicillin and 2 % glucose (from 40 % w / v autoclaved glucose) was inoculated with 4.2 mL of the overnight culture and grown at 37 °C with 200 rpm shaking until an OD600 of 0.6 was reached. Gene expression w as induced by adding isopropyl-|3-D-thiogalactopyranosidc (IPTG) to a final concentration of 1 mM and the induced cultures were incubated at 18 °C for 36 hours with 200 rpm shaking. Cells ere harvested by centrifugation at 4000 x g for 15 min in 50 mL aliquots and the pellets were stored at -20 °C.
[0154] Prediction of the ice nucleation temperatures of INpro aggregates. The HINT algorithm applies Classical Nucleation Theory (CNT) to predict the heterogeneous ice nucleation temperature (Thet) on finite surfaces from experimentally determined thermodynamic and kinetic properties of water and the binding free energy of the ice-nucleating (IN) particle to ice (Aybind)(27). The IN surfaces of En INpro and AfolNpro are modeled as rectangles of width W = 3.4 nm and lengths L = 19 nm ( / fi / INpro) and 25.3 nm (AfolNpro), consistent with AlphaFold3 predictions. Functional aggregates of n INpros are assumed to have widths Wn= n x 3.4 nm and the same lengths, consistent with the assembly model proposed here.
[0155] The algorithm computes the minimum free-energy path AG for nucleating ice on the protein surface and its subsequent growth into the solution as a function of nucleus volume. From the AG profile, it identifies the free-energy barriers and calculates nucleation rates. AG is evaluated using experimental thermodynamic data for water, assuming that the fungal INpro -same as tire bacterial INpro-bind ice as strongly as ice itself (Aybind = -2 / ice-liquid), and have a line tension T = 10 pN for the ice-protein-water three-phase line. Two nucleation barriers, AG*(T), emerge from the analysis: one for ice growth on the protein surface and another for growth into bulk water. The larger barrier limits nucleation and sets Thet. To determine Thet, AG profiles are calculated every 0.1 °C from the melting point to the homogeneous nucleation temperature, and the largest barrier at each temperature is used to compute the heterogeneous nucleation rate. Thet the temperature for which the nucleation frequency is 102 s-1, corresponds to cry stallization at a cooling rate of 1 °C min’1.
[0156] FIGS. 14A and 14B show predicted structures of the fungal AfolNP (FIG. 14A) and tire bacterial INP (FIG. 14B) colored according to functional domains. For AfolNP the N-terminal domain (left end) is followed by tire central [3-solenoid repeat domain (grey) and the disulfide capping motifs are highlighted in yellow. For / MNP the N-terminal domain (alpha helix outside tire central core) is followed by tire central repeat domain (grey) and the charge C-tenninal capping domain (light region right side of core).BSU:2000WG
[0157] FIGS. 15A to 15D present cumulative freezing spectra of bacterial ice nucleators (INs) from P. syringae and fungal INs from E. parvispora measured in water and in the presence of 100 mM dithiothreitol (DTT), a disulfide-reducing agent. Samples were prepared at 0.1 mg / mL and serially diluted tenfold to concentrations from 1 ng / mL to 0.1 mg / mL. For each concentration, the freezing of 96 (3 pL) droplets was followed with a continuous cooling rate of 1 C / min. The cumulative IN number concentration ( n) was calculated using Vali’s method, and it represents the total number of INs that are active above a certain temperature. For bacterial INs, the cumulative freezing spectra in water and in 100 mM DTT are indistinguishable. Both exhibit a first increase at —5.7 °C and a second increase — 7.5 °C followed by a plateau below -9.5 °C, consistent with the presence of two distinct classes of INs with specific activation temperature. The plateaus at temperatures below the increases of / Vm(T) indicate that there are few INs active at these temperature ranges. The absence of any DTT-induced change indicates that reducing conditions do not affect bacterial ice nucleation activity. This observation is consistent with the 7NINP sequence, which contains only a single cysteine residue and therefore lacks stabilizing disulfide bonds.
[0158] For fungal INs, the freezing spectra show a single increase in the / V™(T) of mass — 6 °C followed by a plateau below — 8 °C. In the presence of DTT, the freezing spectrum remains similar, but the cumulative number of INs (Nm) decreases from -1013to 1012. FIG. 15C shows that at the highest concentration the Tso values in pure water -6 °C and in 100 mM DTT — 7 °C, are similar, with Tso defined as the temperature at which 50% of droplets have frozen. However, freezing of a droplet requires only a single active IN, making Tso values measured at a single concentration insufficient to reflect statements on effects on the total number of active INs. FIG. 15C shows that analysis across the dilution series reveals that the number of fungal INs is reduced by more than 90% in the presence of DTT. These results demonstrate that reducing conditions largely abolish the ice nucleation activity of the fungal INs. A / oINPs from E. parvispora contain six cysteine residues near the C-terminal end of the |3-solenoid and two cysteines at the beginning of the fold. These highly conserved cysteines can form disulfide bonds at both termini of the [3-solenoid that likely act as capping structures and stabilize the fold by preventing terminal uncoiling. Upon addition of DTT, these disulfide bonds will be reduced, which would promote solenoid uncoiling and a loss of ice nucleation activity. To support this conclusion, the inventors measured circular dichroism (CD) spectroscopy in water and in the presence of 20 mM tris(2-carboxyethyl)phosphine (TCEP), another well-known reducing agent. FIG. 15D shows CD spectra of AfoINPs in water and in the presence of 20 mM TCEP. Tire CD spectrum of the untreated sample shows a maximum molar ellipticity at —190 nm and a minimum at ~205 nm. Spectral analysis and fold recognition using the web server BeStSel shows that A / oINPs contain a high P-sheet content, consistent with their predicted structure. In the presence of TCEP, the CD spectrum of A / oINPs shows a reduction of the molar ellipticity at -190 nm and an increase in ellipticity -205 nm. These spectral changes show significant changes in the secondary structure oiMoINPs and resemble changes observed after heating A oINPs to 90 °C. These resultsdemonstrate that reduction of the disulfide bonds destabilized the native fold, leading to conformational changes cause the observed loss of ice nucleation activity. Combined, these findings establish a direct link between terminal disulfide-mediated capping, [3-solenoid stability, and ice nucleation activity under reducing conditions.
[0159] To assess how different terminal motifs influence [3-solenoid stability, the inventors examined bacterial and fungal IN activity as a function of pH. Ice nucleation measurements were performed between pH 8 and 12.5, and the cumulative number of INs, Nm(T). was determined from complete dilution series at each condition. FIG. 16A shows cumulative freezing spectra of fungal INs from E. parvispora at selected pH values. At pH 6.5 and pH 12, tire freezing spectra are similar, with an increase — 6 °C followed by a plateau below — 8 °C. At pH 12.5, the increase at — 6 °C remains, but Am(T) decreases by orders of magnitude, indicating near-complete inactivation. FIG. 16B show the freezing spectra of bacterial INs from P. syringae. At pH 6.5, two increases in Am(T) are observed at — 3 °C and — 7 °C with plateaus between approximately -4.5 °C and — 7 °C and below — 9.5 °C. At pH 12, the increase — 3 °C is absent, the lower-temperature increase shifts to — 7.5 °C, and, Am(T) is reduced. At pH 12.5, Nm T) decreases by more than two orders of magnitude, consistent with near-complete loss of activity. The different responses of fungal and bacterial INs under alkaline conditions are summarized in FIG. 16C, which compares cumulative Nm values and Tso at the highest concentration. For bacterial INs, Nm decreases by -60% at pH 12, and at pH and by more than 99% at pH 12.5. In contrast, fungal INs retain Nmat pH 12 and are fully inactivated only at pH 12.5. While the Tso values shift modestly, the dilution-resolved Nm values reveal substantial losses in active INs, emphasizing that singleconcentration metrics underestimate losses in ice nucleation activity. Sequence composition of the INPs is consistent with these differences. TNINP contains 58 positively charged and 81 negatively charged residues, with a calculated isoelectric point of -4.8. Charged residues are distributed along one face of tire [3-solenoid, and in an arginine-rich region near the C-tenninus, while tire C-terminal cap is enriched in acidic amino acids. AfolNP has 55 positively charged and 55 negatively charged residues with a calculated isoelectric point of 5.7 and lacks the arginine-rich region and charged cap. Above pH 10, positively charged amino acids such as lysine and arginine begin to deprotonate (pKa of -10.5 and -12)21, weakening electrostatic interactions that stabilize charged terminal motifs. In bacterial INPs, tire loss of positive charge provides a mechanistic basis for reduced activity under alkaline conditions. This interpretation is consistent with mutational studies showing that removal oftenninal charged coils or substitution of basic residues abolishes bacterial ice nucleation activity.
[0160] To further assess [3-solenoid stability, the inventors examined the effect of temperature on bacterial and fungal IN activity. FIGS. 17A to 17C show the cumulative freezing spectra of bacterial and fungal IN that were subjected to temperatures ranging from 20 °C to 90 °C prior to ice nucleation measurements. FIG. 17A shows that fungal INs at 20 °C exhibit an increase — 6 °C, followed by a plateau at lower temperatures. Heating to 30 - 50 °C causes no measurable changes in onset temperature or the magnitude of Nm. After heating to 60°C and 70 °C, the cumulative freezing spectra remain similar, with minor reductions in Nm. At 80 °C, Nm is strongly reduced, while the increase remains — 6 °C, and at 90 °C Nm decreases by more than two orders of magnitude, indicating near-complete loss of ice nucleation activity.
[0161] FIG. 17B shows that bacterial INs at 20 °C display two distinct increases in Nm at — 3 °C and — 7 °C. It was found that heating bacterial INs eliminates the increase near -3 °C and reduces Nm. Interestingly, a measurable reduction is already apparent after heating to 40 °C and becomes more pronounced at higher temperatures. At 60 °C. Nm is substantially reduced, and at temperatures >70 °C, N decreases by several orders of magnitude, corresponding to near-complete inactivation. Previous reports on the thermal stability of bacterial INPs differed substantially. FIG. 17C summarizes the cumulative Nm values and Tso at tire highest concentration as a function of temperature. For bacterial INs, Nm begins to decrease at ~35 °C and is strongly reduced by 60 °C, with more than 99% of active INs lost at 80 °C and above. The temperature at which -50% of bacterial INs are lost occurs -50 °C, consistent with the CD melting transition reported near 55 °C23. In contrast, fungal INs retain comparable Nm values up to 60 °C, with a pronounced loss only at 80 - 90 °C and a midpoint at -75 °C. In both IN systems, Tso shifts only modestly with increasing temperature relative to the larger reductions in Nm, underscoring that Tso values alone underestimate temperature-induced inactivation.
[0162] Control of [3-solenoid termini has been a major barrier in developing stable solenoid folds, as uncapped ends tend to unravel or misfold. These results identify disulfide-based terminal capping as a previously unrecognized covalent stabilization mechanism for [3-solenoid folds. In fungal INPs, disulfide bonds link and stabilize both tenninal coils, preserving the continuous surface required for efficient ice nucleation. Reduction of these bonds abolishes activity, establishing terminal capping as a key functional determinant of [3-solenoid stability.
[0163] The stability differences between fungal and bacterial INPs are consistent with differences in terminal chemistry, while additional factors, such as membrane-anchoring, further contribute to bacterial INP instabilities. Bacterial INPs rely on electrostatic interactions within a charged C-terminal motif together with membrane-association, both of which are sensitive to pH and temperature. Fungal INPs employ disulfide bonds at the solenoid termini. These covalent linkages enable retention of ice nucleation activity at pH 12, and a thermal midpoint -20 °C higher than that of the bacterial INPs.
[0164] These findings provide a molecular context for the greater environmental persistence and stability of fungal INs reported in nature and suggest that covalent terminal constraints may improve the robustness of [3-solenoid proteins for applications. These results also emphasize the importance of reporting cumulative freezing spectra when assessing IN stability. Tso or median freezing temperature does not quantify the number of active INs and may overlook substantial or complete inactivation. Reliance on single-concentration measurements contributes to inconsistencies in the literature, particularly in studies of highly potent INPs andmutation analyses where reductions in active INs are not reflected by shifts in T50. More broadly, disulfide-mediated terminal capping may provide a design principle for engineering 0-solenoid scaffolds with predictable stability, continuous surfaces, and defined responses to environmental perturbations in biological and materials applications.Genbank: CAO3568755, Mortierella alpina, SEQ ID NO : 12.1 MPDRTVAALL GTMTTADVHQ GQQADLRLER DHTDQHKSAY HEHGNIDSSH HLEDAHEKQH61 RDQETLSIAT DVPVVDVAAV DVTPPPVGGG DAEPHTSVSK VNSGLKHASM KNYKHHYKNA 121 ASRHLRHNKR ALELHLKKAN RHKRNLWHDK EAGILPQTDQ ASSNKKGNSS HAQLTSSREE 181 QRGGLTSTST AQDGTFTAQD SQPCNDTGGD NCIQFGGYNS ILTAGFNSSQ TALGNSTLTA 241 RWGSNQTAGQ ESWLIAGYRS EQTAGIESSL TAGYGSTQAA GEQSVLIAGY GSTSTAGNES 301 SIIAGYGSTQ TAGVESNLTA GYGSTQTARE HSVLTAGYGS TSTAGSDSSL MAGYGSTQTA 361 GYRSDLTAGY GSTQTAQGNS TLFSGYGSTE TAGHQSSLVT GYGSTQTAGT ESSLTAGYGS 421 TQTAREHSVL TAGYGSTSTA GIESSLIAGY GSTQTAGYRS NLTAGYGSTQ TAQDNSTLFA 481 GYGSTETAGH QSSLVTGYGS TQTAGTESSL TAGYGSTQTA REHSVLTAGY GSTSTAGIES 541 SLIAGYGSTQ TAGYRSNLTA GYGSTQTAQD NSTLFAGYGS TETAGHRSSL VTGYGSTQTA 601 GIESSLTAGY GSTQTAREHS VLTAGYGSTS TAGSESILIA GYGSTQTAGV ESSLTAGYGS 661 TQTAREHSVL TAGYGSTSTA GIESSLIAGY GSTQTAGYRS NLTAGYGSTQ TAQDNSTLFA 721 GYGSTETAGH QSSLVTGYGS TQTAGIESSL TAGYGSTQTA REHSVLTAGY GSTSTAGIES 781 SLIAGYGSTQ TAGYRSNLTA GYGSTQTAQD SSTLFAGYGS TETAGHQSSL VTGYGSTQTA 841 GIESSLTAGY GSTQTAREHS VLTAGYGSTS TAGIESSLIA GYGSTQTAGY RSNLTAGYGS 901 TQTAQDSSTL FAGYGSTETA GHQSSLVTGY GSTQTAGTES SLTAGYGSTQ TAREHSVLTA 961 GYGSTSTAGI ESSLIAGYGS TQTAGYRSNL TAGYGSTQTA QDNSTLFAGY GSTETAGHQS 1021 SLIAGYGSTQ TAGIESTLTA GYGSTQTARE HSVLTAGYGS TSTAGSESSL IAGYGSHQTA 1081 HDHSSLTAGY GSTQTAGIES NLTASYGSTQ LASHNSMLVS GSQSNQTAGS HSTLIAGSDS 1141 IQTAGHDSTL YAGANSILVA GDRTKLLAGS NSFITAGDFC QITCGDNCTL ICGRNCTVKT 1201 GANPTVLGGC GDNE
[0165] It is contemplated that any aspects of the disclosure discussed in this specification can be implemented with respect to any method, kit, reagent, or composition of the disclosure, and vice versa. Furthermore, compositions of the disclosure can be used to achieve methods of the disclosure.
[0166] It will be understood that particular aspects described herein are shown by way of illustration and not as limitations of tire disclosure. The principal features of this disclosure can be employed in various aspects without departing from the scope of the disclosure. Those skilled in the art will recognize, or be able to ascertain using no more than routine experimentation, numerous equivalents to the specific procedures described herein. Such equivalents are considered to be within the scope of this disclosure and are covered by the claims.
[0167] All publications and patent applications mentioned in the specification are indicative of the level of skill of those skilled in the art to which this disclosure pertains. All publications and patent applications are herein incorporated by reference to the same extent as if each individual publication or patent application was specifically and individually indicated to be incorporated by reference.
[0168] Tire use of the word “a” or “an” when used in conjunction with the term “comprising” in the claims and / or tire specification may mean “one,” but it is also consistent with tire meaning of “one or more,” “at least one,” and “one or more than one.” The use of the term “or” in the claims is used to mean “and / or” unless explicitly indicated to refer to alternatives only or the alternatives are mutually exclusive, although the disclosure supports a definition that refers to only alternatives and “and / or.” Throughout this application, the term “about” is used to indicate that a value includes the inherent variation of error for the device, the method being employed to determine the value, or tire variation that exists among the study subjects.
[0169] As used in this specification and claim(s), the words “comprising” (and any form of comprising, such as “comprise” and “comprises”), “having” (and any form of having, such as “have” and “has”), “including” (and any form of including, such as “includes” and “include”) or “containing” (and any form of containing, such as “contains” and “contain”) are inclusive or open-ended and do not exclude additional, unrecited elements or method steps. In aspects of any of the compositions and methods provided herein, “comprising” may be replaced with “consisting essentially of’ or “consisting of’. As used herein, the phrase “consisting essentially of’ requires the specified integer(s) or steps as well as those that do not materially affect the character or function of the claimed invention. As used herein, the term “consisting” is used to indicate the presence of the recited integer (e.g., a feature, an element, a characteristic, a property, a method / process step or a limitation) or group of integers (e.g., feature(s), element(s), characteristic(s), propertie(s), method / process steps or limitation(s)) only.
[0170] The term “or combinations thereof’ as used herein refers to all permutations and combinations of the listed items preceding the term. For example, “A, B, C, or combinations thereof’ is intended to include at least one of: A, B, C, AB, AC, BC, or ABC, and if order is important in a particular context, also BA, CA, CB, CBA, BCA, ACB, BAC, or CAB. Continuing with this example, expressly included are combinations that contain repeats of one ormorc item orterm, such as BB, AAA, AB, BBC, AAABCCCC, CBBAAA, CAB ABB,and so forth. The skilled artisan will understand that typically there is no limit on the number of items or terms in any combination, unless otherwise apparent from the context.
[0171] As used herein, words of approximation such as, without limitation, “about”, “substantial” or “substantially” refers to a condition that when so modified is understood to not necessarily be absolute or perfect but would be considered close enough to those of ordinary skill in the art to warrant designating the condition as being present. The extent to which the description may vary will depend on how great a change can be instituted and still have one of ordinary skilled in the art recognize the modified feature as still having the required characteristics and capabilities of the unmodified feature. In general, but subject to the preceding discussion, a numerical value herein that is modified by a word of approximation such as “about” may van from the stated value by at least ±1, 2, 3, 4, 5, 6, 7, 10, 12 or 15%.
[0172] Additionally, the section headings herein are provided for consistency with the suggestions under 37 CFR 1.77 or otherwise to provide organizational cues. These headings shall not limit or characterize the disclosure(s) set out in any claims that may issue from this disclosure. Specifically, and by way of example, although tire headings refer to a “Field of Invention.” such claims should not be limited by the language under this heading to describe the so-called technical field. Further, a description of technology in the “Background” section is not to be construed as an admission that technology is prior art to any disclosure(s) in this disclosure. Neither is the ■’Summary" to be considered a characterization of the disclosure(s) set forth in issued claims. Furthennore, any reference in this disclosure to “invention” in tire singular should not be used to argue that there is only a single point of novelty in this disclosure. Multiple inventions may be set forth according to tire limitations of the multiple claims issuing from this disclosure, and such claims accordingly define the invention(s), and their equivalents, that are protected thereby. In all instances, the scope of such claims shall be considered on their own merits in light of this disclosure but should not be constrained by the headings set forth herein.
[0173] All of the compositions and / or methods disclosed and claimed herein can be made and executed without undue experimentation in light of the present disclosure. While tire compositions and methods of this disclosure have been described in terms of preferred aspects, it will be apparent to those of skill in the art that variations may be applied to the compositions and / or methods and in the steps or in the sequence of steps of the method described herein without departing from the concept, spirit and scope of the disclosure. All such similar substitutes and modifications apparent to those skilled in the art are deemed to be within the spirit, scope and concept of the disclosure as defined by the appended claims.
[0174] To aid the Patent Office, and any readers of any patent issued on this application in interpreting the claims appended hereto, applicants wish to note that they do not intend any of the appended claims to invoke paragraph 6 of 35 U.S.C. § 112, U.S.C. § 112 paragraph (f), or equivalent, as it exists on the date of filing hereof unless the words “means for” or “step for” are explicitly used in the particular claim.
[0175] For each of the claims, each dependent claim can depend both from the independent claim and from each of the prior dependent claims for each and every claim so long as the prior claim provides a proper antecedent basis for a claim term or element.REFERENCES
[0176] 1 Laksmono, H. et al. Anomalous Behavior of the Homogeneous Ice Nucleation Rate in "NoMan's Land". Hie Journal of Physical Chemistry Letters 6, 2826-2832 (2015).
[0177] 2 Zachariassen, K. E. & Kristiansen, E. Ice Nucleation and Antinucleation in Nature. Cryobiology 41. 257-279 (2000).
[0178] 3 Duman, J. G. Antifreeze and Ice Nucleator Proteins in Terrestrial Arthropods. Annual Review of Physiology 63, 327-357 (2001). doi.org:doi.org / 10.1146 / annurev.physiol.63.1.327doi.org:doi.org / 10.1146 / annurev.physioL63.1.327
[0179] 4 Warren, G. J. Bacterial Ice Nucleation: Molecular Biology and Applications. Biotechnol. Genet. Eng. Rev. 5, 107 (1987).
[0180] 5 Kunert, A. T. et al. Macromolecular fungal ice nuclei in Fusarium: effects of physical and chemical processing. Biogeosciences 16, 4647-4659 (2019).
[0181] 6 Eufemio, R. J. et al. Lichen species across Alaska produce highly active and stable ice nucleators. Biogeosciences Discuss. 2023, 1-18 (2023).
[0182] 7 Dreischmeier, K., Budke, C., Wiehemeier, L., Kottke, T. & Koop, T. Boreal pollen contain ice-nucleating as well as ice-binding ‘antifreeze’ polysaccharides. Scientific Reports 7, 41890 (2017).
[0183] 8 Maki, L. R., Galyan, E. L., Chang-Chien, M. M. & Caldwell, D. R. Ice Nucleation Induced by Pseudomonas Syringae. Appl. Microbiol. 28, 456 (1974).
[0184] 9 Schwidetzky, R. et al. Functional aggregation of cell-free proteins enables fungal ice nucleation. Proceedings of the National Academy of Sciences 120, e2303243120 (2023). doi.org:doi: 10.1073 / pnas.2303243120doi.org:doi: 10.1073 / pnas.2303243120
[0185] 10 Atkinson, J. D. et al. The Importance of Feldspar for Ice Nucleation by Mineral Dustin Mixed-Phase Clouds. Nature 498, 355 (2013).
[0186] 11 Marcolli, C., Nagare, B., Welti, A. & Lohmann, U. Ice nucleation efficiency of Agl: review and new insights. Atmos. Chem. Phys. 16, 8915-8937 (2016). doi.org:10.5194 / acp-16-8915-2016
[0187] 12 Frohlich-Nowoisky, J. et al. Bioaerosols in the Earth system: Climate, health, and ecosystem interactions. Atmospheric Research 182, 346-376 (2016). doi.org:doi.org / 10.1016 / j.atmosrcs.2016.07.018BSU:2000WG
[0188] 13 Lindow, S. E. The Role of Bacterial ICE Nucleation in Frost Injun to Plants. Annual Review of Phytopathology 21, 363-384 (1983). doi.org:doi.org / 10.1146 / annurev.py.21.090183.002051
[0189] 14 Warren, G. & Corotto, L. The consensus sequence of ice nucleation proteins from Erwinia hcrbicola, Pseudomonas fluorcsccns and Pseudomonas syringac. Gene 85, 239-242 (1989). doi.org:doi.org / 10.1016 / 0378-l 119(89)90488-5
[0190] 15 Forbes, J. et al. Water-organizing motif continuity is critical for potent ice nucleation protein activity. Nature Communications 13, 5019 (2022). doi.org: 10.1038 / s41467-022-32469-9
[0191] 16 Renzer, G. et al. Hierarchical assembly and environmental enhancement of bacterial ice nucleators. Proceedings of the National Academy of Sciences 121, e2409283121 (2024). doi.org:doi: 10.1073 / pnas.2409283121
[0192] 17 Lindow, S. E. Membrane Fluidity as a Factor in Production and Stability of Bacterial Ice Nuclei Active at High Subfreezing Temperatures. Cryobiology 32, 247-258 (1995).
[0193] 18 Schwidetzky, R. et al. Membranes Are Decisive for Maximum Freezing Efficiency of Bacterial Ice Nucleators. J. Phys. Chem. Lett. 12, 10783 (2021).
[0194] 19 Qiu, Y.. Hudait. A. & Molinero, V. How Size and Aggregation of Ice-Binding Proteins Control Their Ice Nucleation Efficiency. J. Am. Chem. Soc. 141, 7439 (2019).
[0195] 20 Frbhlich-Nowoisky, J. et al. Ice nucleation activity in the widespread soil fungus Mortierella alpina. Biogeosciences 12, 1057-1071 (2015). doi.org: 10.5194 / bg-12-1057-2015
[0196] 21 Pouleur, S.. Richard, C., Martin. J. G. & Antoun. H. Ice Nucleation Activity in Fusarium acuminatum and Fusarium avenaceum. Appl Environ Microbiol 58, 2960-2964 (1992).
[0197] 22 Yang. S.. Rojas, M., Coleman, J. J. & Vinatzer, B. A. Identification of Candidate Ice Nucleation Activity (INA) Genes in Fusarium avenaceum by Combining Phenotypic Characterization with Comparative Genomics and Transcriptomics. loumal of Fungi 8, 958 (2022).
[0198] 23 Eufemio, R. J. et al. Peltigera lichen thalli produce highly efficient ice nucleating agents. EGUsphere 2024, 1-17 (2024). doi.org: 10.5194 / egusphere-2024-2959
[0199] 24 Vandepol, N. et al. Resolving the Mortierellaceae phylogeny through synthesis of multi-gene phylogenetics andphylogenomics. Fungal Diversity 104, 267-289 (2020). doi.org: 10.1007 / s 13225-020-00455-5
[0200] 25 Hansen, T. et al. Ice nucleation proteins self-assemble into large fibres to trigger freezing at near 0 °C. eLife 12, RP91976 (2023). doi.org: 10.7554 / eLife.91976BSU:2000WG
[0201] 26 Gamham, C. P., Campbell, R. L., Walker, V. K. & Davies, P. L. Novel Dimeric Beta-Helical Model of an Ice Nucleation Protein with Bridged Active Sites. BMC Struct. Biol. 11, 36 (2011).
[0202] 27 Hartmann, S. et al. Structure and Protein-Protein Interactions of Ice Nucleation Proteins Drive Their Activity. Frontiers in Microbiology 13 (2022).
[0203] 28 Abramson, J. et al. Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature 630, 493-500 (2024). doi.org: 10.1038 / s41586-024-07487-w
[0204] 29 Li, N., Chibber, B. A. K., Castellino, F. J. & Duman, J. G. Mapping of Disulfide Bridges in Antifreeze Proteins from Overwintering Larvae of the Beetle Dendroides canadensis. Biochemistry 37, 6343-6350 (1998). doi.org: 10.1021 / bi972853i
[0205] 30 Kunert, A. T. et al. Twin-Plate Ice Nucleation Assay (Tina) with Infrared Detection for High-Throughput Droplet Freezing Experiments with Biological Ice Nuclei in Laboratory and Field Samples. Atmos. Meas. Technol. 11, 6327 (2018).
[0206] 31 de Almeida Ribeiro, L, Meister, K. & Molinero, V. HUB: a method to model and extract the distribution of ice nucleation temperatures from drop-freezing experiments. Atmos. Chem. Phys. 23, 5623-5639 (2023).
[0207] 32 Pummer, B. G. et al. Ice nucleation by water-soluble macromolecules. Atmos. Chem. Phys.15, 4077-4091 (2015). doi.org: 10.5194 / acp- 15 -4077-2015
[0208] 33 Pawsey, R. G. & Heath, L. A. F. An investigation of the spore population of the air at Nottingham : I. The results of petri dish trapping over one year. Transactions of the British Mycological Society 47, 351-355 (1964). doi.org:doi.org / 10.1016 / S0007-1536(64)80007-3.
Claims
What is claimed is:
1. An ice-nucleating protein (INP) comprising:an amino acid sequence encoding a central repeating domain (CRD) comprising tandem repeat motifs that adopts a 0-solenoid fold and have at least 90, 91.
92. 93, 94, 95, 96, 97, 98, 99, or 100% sequence identity to the CRD of SEQ ID NO: 1, 2, 3, or 12; andat least one of:an N-terminal flanking peptide immediately upstream of the CRD, wherein the N-terminal flanking peptide comprises at least one pair of cysteine residues spaced apart by no more than about 15 amino acids; ora C-terminal flanking peptide immediately downstream from the CRD, wherein the C- terminal flanking peptide comprises at least one pair of cysteine residues spaced apart by no more than about 15 amino acids;wherein the cysteine residues in the N-terminal flanking peptide, the C-terminal flanking peptide, or both, are capable of forming intramolecular disulfide bonds that stabilize the 0-solenoid fold.
2. The ice-nucleating protein of claim 1, wherein each cysteine pair forms a disulfide bond.
3. The ice-nucleating protein of claim 1. wherein the CRD comprises a plurality of 16-amino acid repeat motifs with a consensus sequence TA(G / T)(S / T)Xn(SEQ ID NO: 7).
4. The ice-nucleating protein of claim 1, wherein N-terminal flanking peptide, the C-terminal flanking peptide, or both, are no more than about 20 amino acids from the CRD are conserved and have at least 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, or 100% sequence identity with one or more flanking cysteine-rich peptides of INPs from Mortierella alpinci, Entomortierella parvispora, or Podilci clonocystis of SEQ ID NO: 1, 2, 3, or 12, respectively.
5. The ice-nucleating protein of claim 1, wherein the INP is expressed in vitro or in a bacteria cell, a fungal cell, a yeast cell, a plant cell, a seed, a plant, an insect cell, a mammalian cell, or a cell infected with a virus.
6. Tire ice-nucleating protein of claim 1, wherein the INP does not comprise a hydrophobic or transmembrane region.
7. The ice-nucleating protein of claim 1. wherein the INP is secreted or free of a cellular membrane.
8. The ice-nucleating protein of claim 1, wherein the INP further comprises one or more protein purification tags selected from at least one of a His-tag, a FLAG-tag, a HA-tag, a Strep-tag, a Strep-II tag, a C9-tag, a glutathione S-transferase tag, HiBiT tag, a maltose-binding protein tag, a T7 tag, a V5 tag, an S tag, a SUMO tag, a TAP tag, a TRX tag, a calmodulin binding peptide, a chitin binding domain, a cellulose binding domain, a E2 epitope, a HaloTag, a HSV tag, a HBH tag, a KT3 tag or a myc-tag.
9. The ice-nucleating protein of claim 1, wherein the CRD is from Mortierella sp., Entomortierella sp., Podila sp., Gryganskiella sp., Pseudomonas sp., Xanthomonas sp., Pantoea sp., Erwinia sp., or Stenolrophomonas sp.
10. The ice-nucleating protein of claim 1, wherein the CRD is from a microorganism listed in Table 1.
11. A process for obtaining an ice-nucleating protein comprising:expressing in vitro or in a cell the ice -nucleating protein comprising an amino acid sequence encoding a central repeating domain (CRD) comprising tandem repeat motifs that adopts a 0-solenoid fold and have at least 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, or 100% sequence identity to the CRD of SEQ ID NO: 1, 2, 3, or 12; andat least one of:an N-terminal flanking peptide immediately upstream of the CRD, wherein the N-terminal flanking peptide comprises at least one pair of cysteine residues spaced apart by no more than about 1 amino acids; ora C-terminal flanking peptide immediately downstream from the CRD, wherein the C- terminal flanking peptide comprises at least one pair of cysteine residues spaced apart by no more than about 15 amino acids;wherein the cysteine residues in the N-terminal flanking peptide, the C-terminal flanking peptide, or both, are capable of forming intramolecular disulfide bonds that stabilize the [1-solcnoid fold.
12. Dre process of claim 11, wherein an extract of the cell, a supernatant, or a whey thereof, does not comprise a lipid or hydrophobic portion of the extract.
13. The process of claim 11, wherein growing at least one of aMortirella alpina (AfoINP), Entomortierella parvispora (Enl N P), or Podila clonocytis (EoINP) in a media at a first temperature and then growing in the media at a second temperature of about 0 to 10 degrees Celsius:extracting from the at least one of aMortirella alpina (A / oINP), Entomortierella parvispora ( / •NINP). or Podila clonocytis ( oINP) fungus; suspending and vortexing the extract in a solution; and isolating the ice-nucleating protein from the solution.
14. The process of claim 13, wherein isolating the ice -nucleating protein from the solution is by centrifugation, precipitation, settlement, or filtration.
15. The process of claim 13, wherein the solution is water and the first temperature is about room temperature.
16. Dre process of claim 11, wherein the ice-nucleating protein is isolated from at least one of spores or mycelial surfaces.
17. The process of claim 11, wherein the ice-nucleating protein further comprising one or more protein purification tags selected from at least one of a His-tag, a FLAG-tag, a HA-tag, a Strep-tag, a Strep-II tag. a C9-tag, a glutathione S-transferase tag, HiBiT tag, a maltose-binding protein tag, a T7 tag, a V5 tag, an S tag,BSU:2000WGa SUMO tag, a TAP tag, a TRX tag, a calmodulin binding peptide, a chitin binding domain, a cellulose binding domain, a E2 epitope, a HaloTag, a HSV tag, a HBH tag, a KT3 tag or a myc-tag.
18. The process of claim 11, wherein the ice-nucleating protein does not comprise a hydrophobic or transmembrane region.
19. The process of claim 11 , wherein the ice-nucleating protein is expressed in a cell other than M. alpina (A / oINP), E. parvispora (AhlNP). or P. clonocytis (PoINP).
20. The process of claim ll, wherein the ice-nucleating protein is expressed in a fungi, yeast, bacteria, plant cell, seed, plant, insect, cyanobacteria, archacai, protist, or mammalian cell.
21. The process of claim 11, wherein the CRD is from Mortierella sp., Entomortierella sp., Podila sp., Gryganskiella sp.. Pseudomonas sp., Xanthomonas sp., Pantoea sp., Erwinia sp., Stenotrophomonas sp.
22. The process of claim 11, wherein the CRD is from a microorganism listed in Table 1.
23. An aqueous extract comprising an ice-nucleating protein (INP) comprising:an amino acid sequence encoding a central repeating domain (CRD) comprising tandem repeat motifs that adopts a -solenoid fold and have at least 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, or 100% sequence identity to the CRD of SEQ ID NO:
1. 2, 3, or 12; andat least one of:an N-terminal flanking peptide immediately upstream of the CRD, wherein the N-terminal flanking peptide comprises at least one pair of cysteine residues spaced apart by no more than about 15 amino acids; ora C-terminal flanking peptide immediately downstream from the CRD, wherein the C-tenninal flanking peptide comprises at least one pair of cysteine residues spaced apart by no more than about 15 amino acids;wherein the cysteine residues in the N-terminal flanking peptide, the C-terminal flanking peptide, or both, are capable of forming intramolecular disulfide bonds that stabilize the 0-solcnoid fold.
24. The aqueous extract of claim 23, wherein the INP from at least one of M. alpina (AfolNP), Entomortierella ( / TdNP). or P. clonocytis (foINP) having at least 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, or 100% sequence identity to a central repeating domain (CRD) of SEQ ID NOS: 1, 2, 3, or 12, respectively, wherein at least one of the Mortirella alpina (AfolNP), Entomortierella parvispora (E INP), or Podila clonocytis (PoINP) is grown in a media at a first temperature and then growing in the media at a second temperature of about 0 to 10 degrees Celsius prior to extraction.
25. The aqueous extract of claim 23, wherein the aqueous extract comprises protein having an apparent molecular weight of 100 kDa, 81.8 kDa, and 64 kD, respectively.
26. The aqueous extract of claim 23, wherein the aqueous extract does not comprise a lipid or hydrophobic portion.
27. The aqueous extract of claim 23, further comprising one or more protein purification tags selected from at least one of a His-tag, a FLAG-tag, a HA-tag, a Strep-tag, a Strep-II tag, a C9-tag, a glutathione S-transferase tag, HiBiT tag, a maltose-binding protein tag, a T7 tag, a V5 tag. an S tag, a SUMO tag, a TAP tag, a TRX tag, a calmodulin binding peptide, a chitin binding domain, a cellulose binding domain, a E2 epitope, a HaloTag, a HSV tag, a HBH tag, a KT3 tag or a myc-tag.
28. The aqueous extract of claim 23, wherein the ice-nucleating protein does not comprise a hydrophobic or transmembrane region.
29. A polynucleotide that expresses an ice-nucleating protein (INP) comprising:a nucleic acid sequence encoding a central repeating domain (CRD) comprising tandem repeat motifs that adopts a 0-solenoid fold and have at least 90, 91, 92, 93, 94, 95.
96. 97, 98, 99, or 100% sequence identity to the CRD of SEQ ID NO: 4, 5, or 6; andat least one of:an N-terminal flanking peptide immediately upstream of the CRD, wherein the N-terminal flanking peptide comprises at least one pair of cysteine residues spaced apart by no more than about 15 amino acids; ora C-terminal flanking peptide immediately downstream from the CRD, wherein the C-terminal flanking peptide comprises at least one pair of cysteine residues spaced apart by no more than about 15 amino acids;wherein the cysteine residues in the N-terminal flanking peptide, the C-terminal flanking peptide, or both, are capable of forming intramolecular disulfide bonds that stabilize the 0-solenoid fold.
30. The polynucleotide of claim 29, further comprising a vector.
31. The polynucleotide of claim 30. wherein the vector is in a host cell.
32. The polynucleotide of claim 29, wherein codon-usage of the polynucleotide is optimized for expression in a bacteria, fungi, insect, plant, or mammalian cell.
33. A method for increasing ice nucleation per microorganism, extract, supernatant, whey, or protein, comprising the steps of:blowing at least one stream of snow-like particles or snowflakes into ambient air, the ambient air having a temperature just above, or below, a freezing point of water;forming an aqueous mixture comprising an ice-nucleating microorganism, extract, supernatant, whey, or protein comprising an amino acid sequence encoding a central repeating domain (CRD) comprising tandem repeat motifs that adopts a 0-solenoid fold and have at least 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, or 100% sequence identity to the CRD of SEQ ID NO: 1, 2, 3, or 12; andat least one of:an N-terminal flanking peptide immediately upstream of the CRD, wherein the N-terminal flanking peptide comprises at least one pair of cysteine residues spaced apart by no more than about 15 amino acids; ora C-terminal flanking peptide immediately downstream from the CRD, wherein the C-terminal flanking peptide comprises at least one pair of cysteine residues spaced apart by no more than about 15 amino acids;wherein the cysteine residues in the N-terminal flanking peptide, the C-terminal flanking peptide, or both, arc capable of forming intramolecular disulfide bonds that stabilize the 0-solcnoid fold; and directing a spray or mist of water droplets into the stream to form snow or ice.
34. The method of claim 33, wherein the snow-like particles or snowflakes act as nucleating agents for water droplets to assist in formation of the snowflakes.
35. The method of claim 33, further comprising adding at least a portion of the snowflakes to the snow-like particles, wherein the snowflakes also provide a nucleating activity to water droplets.
36. Tire method of claim 33, wherein the snowflakes are added to the snow-like particles until a desired quantity of snow has been produced.
37. The method of claim 33, wherein the snow-like particles are formed from block- or chipped-ice in a snow-making machine.
38. The method of claim 33, further comprising adding a polyol to the aqueous mixture selected from at least one of: sorbitol, maltitol, xylitol, erythritol, mannitol, isomalt, lactitol, or glycerol.
39. An apparatus for making snow, comprising:a snow -making machine having at least one chamber;a first inlet to the chamber operably connected to a source of ice or recycled snowflakes;a rotatable impeller within the chamber operable to form snow-like particles from ice;an outlet from the chamber operable to direct the snow-like particles formed within the chamber to be blown in a directed stream into ambient air having a temperature just above, or below, a freezing point of water; andat least one water sprayer, connected to a water source and an ice nucleating protein comprising an amino acid sequence encoding a central repeating domain (CRD) comprising tandem repeat motifs that adopts a 0-solenoid fold and have at least 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, or 100% sequence identity to the CRD of SEQ ID NO: 1, 2, 3, or 12; andat least one of:an N-terminal flanking peptide immediately upstream of tire CRD, wherein the N-temiinal flanking peptide comprises at least one pair of cysteine residues spaced apart by no more than about 15 amino acids; ora C-terminal flanking peptide immediately downstream from the CRD, wherein the C-terminal flanking peptide comprises at least one pair of cysteine residues spaced apart by no more than about 15 amino acids;wherein the cysteine residues in the N-terminal flanking peptide, the C-terminal flanking peptide, or both, are capable of forming intramolecular disulfide bonds that stabilize the P-solenoid fold.
40. The apparatus of claim 39, wherein the snow-like particles or snowflakes act as nucleating agents for water droplets to assist in formation of the snowflakes.
41. Tire apparatus of claim 39, further comprising adding at least a portion of the snowflakes to the snow-like particles, wherein the snowflakes also provide a nucleating activity to ater droplets.
42. The apparatus of claim 39, wherein the snowflakes are added to the snow-like particles until a desired quantity of snow’ has been produced.
43. The apparatus of claim 39, wherein the snow-like particles are formed from block- or chipped-ice in a sno -making machine.
44. A method of preserving a biological sample, the method comprising:perfusing or contacting a biological sample with a composition comprising a non-toxic microorganism, extract, or protein thereof that expresses an ice nucleating protein comprising an amino acid sequence encoding a central repeating domain (CRD) comprising tandem repeat motifs that adopts a P-solenoid fold and have at least 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, or 100% sequence identity to the CRD of SEQ ID NO: 1, 2, 3, or 12; andat least one of:an N-tenninal flanking peptide immediately upstream of tire CRD, wherein the N-terminal flanking peptide comprises at least one pair of cysteine residues spaced apart by no more than about 15 amino acids; ora C-terminal flanking peptide immediately downstream from the CRD, wherein the C-terminal flanking peptide comprises at least one pair of cysteine residues spaced apart by no more than about 15 amino acids;wherein the cysteine residues in the N-terminal flanking peptide, the C-terminal flanking peptide, or both, are capable of forming intramolecular disulfide bonds that stabilize the P-solenoid fold;freezing the biological sample with the composition; andcry opreserving the biological sample at a high subzero temperature.
45. Dre method of claim 44, wherein the method further comprises thawing the biological sample.
46. The method of claim 44, wherein the biological sample comprises a cell, a tissue sample, an exosome, or a microvesicle.
47. The method of claim 44, wherein the composition further comprises a cryoprotectant selected from any one or more of dimethylsulfoxide, ethylene glycol, propylene glycol, propane-1, 2-diol, 1,2-propanediol, 3-O-methyl-glucose, glycerol, sucrose, trehalose, stachyose, raffinose, an anti-freeze protein, or a polymer.
48. The method of claim 44, wherein a concentration of the ice nucleating protein in the hydrogel particle is greater than 0.5 mg / ml.
49. The method of claim 44, wherein a hydrogel particle can increase an ice nucleation temperature of a sample to higher than -5° C.
50. Tire method of claim 44, wherein the biological sample is an organ.
51. The method of claim 50, wherein the organ is a liver, a heart, or a kidney.
52. The method of claim 50, wherein the method minimizes ischemia-reperfusion damage of the organ.
53. A process for freezing a water-based material that comprises mixing the water-based material with a non-toxic microorganism, extract, supernatant, whey, or protein an amino acid sequence encoding a central repeating domain (CRD) comprising tandem repeat motifs that adopts a P-solenoid fold and have at least 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, or 100% sequence identity to the CRD of SEQ ID NO: 1, 2, 3, or 12; and at least one of:an N-terminal flanking peptide immediately upstream of tire CRD, wherein the N-terminal flanking peptide comprises at least one pair of cysteine residues spaced apart by no more than about 15 amino acids; ora C-terminal flanking peptide immediately downstream from the CRD, wherein the C-tenninal flanking peptide comprises at least one pair of cysteine residues spaced apart by no more than about 15 amino acids;wherein the cysteine residues in the N-terminal flanking peptide, the C-terminal flanking peptide, or both, are capable of forming intramolecular disulfide bonds that stabilize the P-solenoid fold,wherein the microorganism, ice nucleating extract or ice nucleating protein induces ice nucleation and freezing of the water-based material at a temperature below -5° C. to produce a frozen product.
54. The process of claim 53, wherein a water-based material is a foodstuff, a paint, an acid, or a material with at least 10% water.
55. The process of claim 53, further comprising storing a frozen foodstuff in cold storage.
56. The process of claim 53, wherein a foodstuff is liquid or semi-solid at room temperature.
57. Tire process of claim 53, wherein a foodstuff is ice cream or tofu confectionery, a fruit juice concentrate, a popsicle, a sauce, a soup, a sorbet, a gelato, a frozen yogurt, or a sherbet.
58. A water capture material, comprising:a microorganism, supernatant, whey, extract, or isolated ice nucleating protein (INP) comprises an amino acid sequence encoding a central repeating domain (CRD) comprising tandem repeat motifs thatadopts a P-solenoid fold and have at least 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, or 100% sequence identity to the CRD of SEQ ID NO: 1, 2, 3, or 12; andat least one of:an N-terminal flanking peptide immediately upstream of tire CRD, wherein the N-terminal flanking peptide comprises at least one pair of cysteine residues spaced apart by no more than about 15 amino acids; ora C-terminal flanking peptide immediately downstream from the CRD, wherein the C-terminal flanking peptide comprises at least one pair of cysteine residues spaced apart by no more than about 15 amino acids;wherein the cysteine residues in the N-terminal flanking peptide, the C-terminal flanking peptide, or both, are capable of forming intramolecular disulfide bonds that stabilize the P-solenoid fold;wherein the microorganism, whey, supernatant or ice nucleating protein extract or ice nucleating protein induces ice nucleation at a temperature below -5° C;wherein the water capture material is configured to condense water vapor into liquid water and desorb water vapor from the water capture material.
59. The water capture material of claim 58, further defined as at least one water harvesting device that encloses the water capture material.
60. Dre water capture material of claim 58, wherein tire water capture material is configured to adsorb water from surrounding air in adsorption mode.
61. The water capture material of claim 58, further comprising: a heating element, and a condensing unit, wherein in production mode, the heating element is configured to heat the water capture material to induce desorption of water vapor from the water capture material; and a condensing unit is configured to condense the water vapor into the water capture material.
62. Dre water capture material of claim 58, further comprising a cooling element that condenses water vapor released from the water capture material to liquid water.
63. The water capture material of claim 58, wherein the water capture material is attached to a substrate.
64. The water capture material of claim 58, further comprising: a control system configured to monitor and control adsorption, desorption, and condensation of water from the water capture material.
65. A method of harvesting water from surrounding air using an atmospheric harvester comprising: providing one or more water capture units configured to condense water vapor into liquid water or ice and desorb water vapor from tire water capture material comprising a water capture material comprising a microorganism, whey, extract, or ice nucleating protein an amino acid sequence encoding a central repeating domain (CRD) comprising tandem repeat motifs that adopts a P-solenoid fold and have at least 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, or 100% sequence identity to the CRD of SEQ ID NO: 1, 2, 3, or 12; andat least one of:an N-terminal flanking peptide immediately upstream of the CRD, wherein the N-terminal flanking peptide comprises at least one pair of cysteine residues spaced apart by no more than about 15 amino acids; ora C-terminal flanking peptide immediately downstream from the CRD, wherein the C-terminal flanking peptide comprises at least one pair of cysteine residues spaced apart by no more than about 15 amino acids;wherein the cysteine residues in the N-terminal flanking peptide, the C-terminal flanking peptide, or both, arc capable of forming intramolecular disulfide bonds that stabilize the 0-solcnoid fold,wherein the microorganism, whey, extract or ice nucleating protein induces ice nucleation at a temperature below -5° C;adsorbing moisture from air in the one or more water capture units comprising the water capture material;desorbing water vapor from the water capture material in the at least one unit containing w ater capture material; andcondensing the water vapor to produce liquid water.
66. The method of claim 65, further defined as at least one water harvesting device that encloses the water capture material.
67. Tire method of claim 65, wherein the water capture material is configured to adsorb w ater from surrounding air in adsorption mode.
68. The method of claim 65, further comprising providing: a heating element, and a condensing unit, wherein in production mode, the heating element is configured to heat the water capture material to induce desorption of water vapor from the water capture material; and a condensing unit is configured to condense the water vapor into the water capture material.
69. Tire method of claim 65, further comprising providing: a cooling element that condenses w ater vapor released from the water capture material to liquid water.
70. The method of claim 65, wherein the water capture material is attached to a substrate.
71. The method of claim 65, further comprising providing: a control system configured to monitor and control adsorption, desorption, and condensation of water from the water capture material.
72. A composition for production of ice nucleation, snow, rain, cloud seeding, weather modification, cloud condensation, artificial cloud creation, ice nucleation in the atmosphere, hail suppression, or fog dispersal comprising:a dispersion of an ice -nucleating protein (1NP), the INP comprising:an amino acid sequence encoding a central repeating domain (CRD) comprising tandem repeat motifs that adopts a [3-solenoid fold and have at least 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, or 100% sequence identity to the CRD of SEQ ID NO: 1, 2, 3, or 12; andat least one of:an N-terminal flanking peptide immediately upstream of the CRD, wherein the N-tenninal flanking peptide comprises at least one pair of cysteine residues spaced apart by no more than about 15 amino acids; ora C-terminal flanking peptide immediately downstream from the CRD, wherein the C-terminal flanking peptide comprises at least one pair of cysteine residues spaced apart by no more than about 1 amino acids;wherein the cysteine residues in tire N-tcnninal flanking peptide, the C -terminal flanking peptide, or both, are capable of forming intramolecular disulfide bonds that stabilize tire 0-solenoid fold,wherein the INP is in an amount sufficient to produce ice nucleation, snow, rain, cloud seeding, weather modification, cloud condensation, artificial cloud creation, ice nucleation in tire atmosphere, hail suppression, or fog dispersal.
73. Tire composition of claim 72, wherein tire dispersion further comprises a substrate, carrier, diluent, buffer, protease inhibitors, solvent, salt, or combinations thereof.
74. The composition of claim 72, wherein the dispersion further comprises a carrier or substrate selected from lignin, quartz, feldspar, cellulose, combinations and nanoparticles thereof for aerosolization.
75. The composition of claim 72, further comprising one or more agents or indicia for tracing the rain, snow, or precipitation from seeding with the INP.
76. Tire composition of claim 72, wherein the INPs are loaded into a cloud seeding flare or a dispersal apparatus.
77. The composition of claim 72, wherein the INPs are expressed in vitro or in a bacteria cell, a fungal cell, a yeast cell, a plant cell, a seed, a plant, an insect cell, a mammalian cell, or a cell infected with a virus, or a supernatant thereof.
78. A method for ice nucleation, production of snow, rain, cloud seeding, weather modification, as cloud condensation nuclei, artificial cloud creation, atmospheric ice nucleation, hail suppression, or fog dispersal, comprising:applying to a target region a dispersion of an ice-nucleating protein (INP), the INP comprising: an amino acid sequence encoding a central repeating domain (CRD) comprising tandem repeat motifs that adopts a 0-solenoid fold and have at least 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, or 100% sequence identity to the CRD of SEQ ID NO: 1, 2, 3, or 12; andat least one of:an N-tenninal flanking peptide immediately upstream of tire CRD, wherein the N-terminal flanking peptide comprises at least one pair of cysteine residues spaced apart by no more than about 15 amino acids; ora C-terminal flanking peptide immediately downstream from the CRD, wherein the C-terminal flanking peptide comprises at least one pair of cysteine residues spaced apart by no more than about 15 amino acids;wherein the cysteine residues in the N-terminal flanking peptide, the C-terminal flanking peptide, or both, are capable of forming intramolecular disulfide bonds that stabilize the P-solenoid fold,wherein the INP is provided in an amount sufficient to produce ice nucleation, snow, rain, cloud seeding, weather modification, as cloud condensation nuclei, artificial cloud creation, atmospheric ice nucleation, hail suppression, or fog dispersal.
79. The method of claim 78, wherein the dispersion further comprises a substrate, carrier, diluent, buffer, protease inhibitors, solvent, salt, or combinations thereof.
80. The method of claim 78, wherein the dispersion further comprises a carrier or substrate selected from lignin, quartz, feldspar, cellulose, combinations and nanoparticles thereof for aerosolization.
81. Tire method of claim 78, further comprising adding one or more agents or indicia for tracing the rain, snow, or precipitation from seeding with the INP.
82. The method of claim 78, wherein the INPs are loaded into a cloud seeding flare or a dispersal apparatus.
83. The method of claim 78, wherein the INPs are expressed in vitro or in a bacteria cell, a fungal cell, a yeast cell, a plant cell, a seed, a plant, an insect cell, a mammalian cell, or a cell infected with a virus, or a supernatant thereof.
84. A method for detecting the effectiveness of ice nucleation, production of snow, rain, cloud seeding, weather modification, as cloud condensation nuclei, artificial cloud creation, atmospheric ice nucleation, hail suppression, or fog dispersal, comprising:dispersing an ice-nucleating protein (INP) into a target for ice nucleation, production of snow, rain, cloud seeding, weather modification, as cloud condensation nuclei, artificial cloud creation, atmospheric ice nucleation, hail suppression, or fog dispersal, the INP comprising:an amino acid sequence encoding a central repeating domain (CRD) comprising tandem repeat motifs that adopts a p-solenoid fold and have at least 90, 91. 92, 93, 94, 95, 96, 97, 98, 99, or 100% sequence identity to the CRD of SEQ ID NO:
1. 2, 3, or 12; andat least one of:an N-terminal flanking peptide immediately upstream of the CRD, wherein the N-terminal flanking peptide comprises at least one pair of cysteine residues spaced apart by no more than about 15 amino acids; ora C-terminal flanking peptide immediately downstream from the CRD, wherein the C-terminal flanking peptide comprises at least one pair of cysteine residues spaced apart by no more than about 15 amino acids;wherein the cysteine residues in the N-tenninal flanking peptide, the C-terminal flanking peptide, or both, are capable of forming intramolecular disulfide bonds that stabilize the 0-solenoid fold;capturing one or more water or dust samples from a location downstream from the region seeded; andmeasuring in the one or more water or dust samples an amount of INP in the one or more water or dust samples to determine if the INP produced desired ice nucleation, production of snow, rain, cloud seeding, weather modification, as cloud condensation nuclei, artificial cloud creation, atmospheric ice nucleation, hail suppression, or fog dispersal.
85. The method of claim 84, wherein the INP is measured by mass spectrometry , multiplex methods, Western blot, enzyme-linked immunosorbent assay (ELISA), sandwich ELISA, fluorescent-linked immunosorbent assay (FLISA), enzyme immunoassay (EIA), radioimmunoassay (RIA), electrochemiluminescence immunoassay, chemiluminescence immunoassay, an immuno assay based on detection of luminescence, fluorescence, chemiluminescence or electrochemiluminescence, immunoprecipitation assay, slot / blot assay, lateral flow assay, single molecule array, agglutination, high perfonnance liquid chromatography (HPLC), thin layer chromatography (TLC), or combinations thereof.
86. The method of claim 84, wherein an anti-INP antibody is used for Western blot, enzyme-linked immunosorbent assay (ELISA), sandwich ELISA, fluorescent-linked immunosorbent assay (FLISA), enzyme immunoassay (EIA), radioimmunoassay (RIA), electro-chemiluminescence immunoassay, chemiluminescence immunoassay, an immuno assay based on detection of luminescence, fluorescence, chemiluminescence or electrochemiluminescence, immunoprecipitation assay, slot / blot assay, lateral flow assay, single molecule array, or agglutination.
